US20040059406A1 - Medical device amenable to fenestration - Google Patents
Medical device amenable to fenestration Download PDFInfo
- Publication number
- US20040059406A1 US20040059406A1 US10/251,031 US25103102A US2004059406A1 US 20040059406 A1 US20040059406 A1 US 20040059406A1 US 25103102 A US25103102 A US 25103102A US 2004059406 A1 US2004059406 A1 US 2004059406A1
- Authority
- US
- United States
- Prior art keywords
- medical device
- implantable medical
- framework
- barrier material
- implantable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/821—Ostial stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
Definitions
- the present invention relates to implantable medical devices. More particularly, the invention relates to means for forming a framed aperture in wall portions, or other partitions, of implantable medical devices to establish and maintain fluid communication across the wall portion of the medical device. The present invention also relates to methods of making the invention.
- AAAs Abdominal aortic aneurysms
- TAAs thoracic aortic aneurysms
- AAAs Abdominal aortic aneurysms
- TAAs thoracic aortic aneurysms
- stent-graft devices typically require some amount of healthy vessel both proximal and distal to the aneurysm sac into which to place the stent-graft.
- the proximal vessel is not long enough to achieve adequate fixation. Placement of the stent-graft in a more proximal location in these patients in order to achieve adequate fixation could partially or completely occlude the renal arteries providing blood to the kidneys.
- suprarenal fixation A number of different device designs have been proposed to allow device fixation to the aortic vessel proximal to the renal arteries (i.e., suprarenal fixation). Widespread applicability of supra-renal fixation devices has been limited by the flexibility of these designs, morphological variation of aneurysmal neck geometry across patients, and the coverage of the renal ostia with metallic stents which can act as a nidus for thromo-embolism of the renal circulation and/or hinder subsequent interventional access to this vasculature.
- TAA disease A similar situation exists for TAA disease. These aneurysmal lesions are often located in close proximity to the subclavian and carotid arterial branches. When inadequate proximal vascular tissue is available for anchoring the endoprosthesis, a suitable proximal anchoring zone can be created by performing a surgical transposition prior to the interventional procedure. This surgical approach is intended to assure continued flow to all vessels. Alternative means for achieving side-branch perfusion through the wall of a stent-graft are therefore desirable.
- Fontan procedure is an example of a staged surgical treatment that is designed to overcome these significant structural heart abnormalities and isolate systemic and pulmonary circulation at the definitive treatment.
- the final surgical procedure involves either surgical closure or transcatheter occlusion of the temporary hole in the IVC to PA connector tube.
- This multi-staged conventional surgical approach for patients with complex congenital heart disease is not optimal as it puts patients at additional risk of morbidity and mortality with each subsequent surgical intervention. This risk may be reduced if the first surgical intervention can set the stage for a future minimally invasive procedure that eliminates the need for additional open-heart surgery.
- U.S. Pat. No. 6,398,803 issued to Layne, et. al., relates to partially covered stents having various patterns of open apertures along the length of the device. As with the Wisselink and Castaneda devices, the apertures are fully formed prior to deployment of the device.
- U.S. Pat. No. 6,432,127 issued to Kim, et. al., discloses formation of an aperture in the wall of a vascular conduit through the use of a cutting tool.
- the conduit does not provide a deformable framework encompassing the aperture formation site.
- targeting the precise location of the region in which to create the aperture is difficult to visualize using conventional imaging techniques.
- the aperture is not reinforced along its peripheral regions once the aperture is formed. The absence of a framework delimiting the aperture formation site precludes precise sizing of the aperture during its formation.
- the present invention is directed to a device that is amenable to transmural fenestration.
- the present invention permits a permanent framed aperture to be formed in a wall, or similar partition, of implantable medical devices as a means for establishing and maintaining fluid communication across the wall of the medical device following implantation.
- the present invention provides a breachable barrier material that initially maintains the continuity and any fluid-retaining properties of the wall of the medical device.
- the breachable barrier material fully covers an opening delimited by a framework. In use, the breachable barrier material is breached with a surgical instrument and the shape of the framework altered to enlarge, or otherwise alter, the area of the opening. In the process, the opening becomes uncovered and accessible to flow of fluid through the opening.
- the altered framework provides structural reinforcement to peripheral regions (e.g., circumferential) of the enlarged opening and forms a permanent aperture in the wall of the medical device.
- the altered framework can also be used to provide a secure anchoring site for ancillary medical devices.
- the permanent aperture can be formed in the wall of the implantable medical device at the time of surgical or catheter-based intervention or at a later date through the use of interventional or surgical techniques.
- the present invention is particularly suited for use with vascular prostheses, and other implantable medical devices providing fluid containment or fluid partitioning, that can benefit from the formation of one or more permanent apertures in the devices at the implantation site.
- the invention can provide a framed aperture in the wall of the stent-graft for side-branches or drainage sites.
- Vascular grafts can be bypassed or bifurcated in-situ with the present invention.
- the invention can also be used with surgically implanted cardiovascular patches to provide perfusion or other access to the heart and vascular system.
- the present invention can be added to an implantable medical device following its construction, or included in the manufacture of the device as an integral component.
- the breachable barrier material of the present invention is made of implantable polymers that are readily breached, perforated, or otherwise structurally disrupted with surgical instruments.
- the breachable barrier material can also be made of polymers that are structurally disrupted through degradation and absorption by the body of the implant recipient.
- the polymers of the breachable barrier material can be incorporated with filler materials to assist in breaching the barrier material or to facilitate visualization of the aperture region in an implant recipient.
- the framework is made of implantable metallic or polymeric materials that can be altered in shape. These framework materials can be deformed or otherwise altered in shape with surgical instruments or have shape-memory properties that permit the framework to assume different shapes without the use of an instrument.
- the framework materials are shaped in various ways to assist in the combined roles of structurally reinforcing the breachable barrier material and the opening, being capable of reconfiguration, and providing a permanent framed aperture.
- an implantable medical device utilizing the present invention is placed at a surgical site with conventional or interventional surgical techniques.
- a catheter guide-wire, or other surgical instrument is used to breach the breachable barrier material and begin to uncover the covered opening.
- An expandable balloon catheter in a deflated configuration is then inserted into the partially uncovered opening and inflated.
- the balloon catheter is inflated, it expands in diameter, altering the shape of the framework and displacing the remaining barrier material from the area of the opening.
- the balloon catheter is deflated and removed from the opening. This leaves a permanent framed aperture in the wall of the medical device.
- the permanent aperture can provide immediate therapies and surgical remedies, such as branch vessel perfusion, or co-operate with other medical devices.
- the present invention is an implantable medical device comprising a framework delimiting an opening having a first area and a breachable barrier material fully covering said opening, wherein a permanent aperture having a second area is formed following breach of said breachable material and said framework is adaptable to be altered in shape.
- the present invention is an implantable medical device comprising a continuous wall, at least one framework in said wall delimiting an opening having a first area, a breachable barrier material fully covering said opening, wherein a permanent aperture having a second area is formed following breach of said breachable material and said framework is adaptable to be altered in shape and have a reinforced peripheral region in said continuous wall.
- FIG. 1A illustrates a top view of the present invention.
- FIGS. 1 B- 1 D illustrate a side view of the present invention.
- FIGS. 2 A- 2 E illustrate the present invention in operation.
- FIG. 3A illustrates an embodiment of the present invention incorporated into a wall of a tubular medical device.
- FIG. 3B illustrates an embodiment of the present invention incorporated into a planar material that is attached to a wall of a tubular medical device.
- FIG. 4 illustrates an embodiment of the present invention incorporated into a medical device.
- FIG. 4A illustrates an embodiment of the present invention placed in a discrete location relative to scaffolding and wall elements of an implantable medical device.
- FIG. 5 illustrates an abdominal aortic aneurysm.
- FIG. 6 illustrates a stent-graft incorporating an embodiment of the present invention placed in the region of an abdominal aortic aneurysm.
- FIGS. 7 A- 7 D illustrate the present invention being utilized to provide perfusion to side branches of a blood vessel.
- FIG. 7E illustrates an embodiment of the present invention serving as attachment means for another medical device.
- FIGS. 8 A- 8 C illustrate the framework component of the present invention in various non-limiting shapes.
- FIG. 9 illustrates the framework component of the present invention in the form of an array.
- FIG. 10 illustrates the framework component of the present invention in the form of an array.
- FIG. 11 illustrates a method of constructing the breachable barrier material in an embodiment of the present invention.
- FIG. 12 is an exploded view of an embodiment of the present invention under construction.
- FIG. 13 is a perspective view of an embodiment of the present invention.
- AAA Abdominal Aortic Aneurysm
- the present invention can be used in combination with a variety of implantable fluid-containing medical devices to establish fluid communication across a wall, or other partition, in the devices.
- the present invention is employed at the time the medical device is implanted.
- the present invention is accessed and utilized after the medical device has been implanted for a period of time.
- the present invention can also be used before the implant procedure begins.
- FIG. 1A is a top view of an embodiment of the present invention 10 incorporated into an implantable patch material 12 .
- FIG. 1B is a side view of this embodiment generally illustrating the relationship of the components.
- a framework 14 is surrounded by a layer of implantable polymeric material 18 .
- the framework 14 delimits an opening 16 that is fully covered with a breachable barrier material 17 .
- the polymer layer 18 is sandwiched between two layers of implantable patch material 12 , 13 so as to reveal the framework 14 , opening 16 , and breachable barrier material 17 of the present invention.
- the implantable patch material or other wall components are considered part of the invention.
- Implantable medical devices having tubular configurations are also suitable for use with the present invention.
- Tubular medical devices are generally cylindrical in shape and not confined to having parallel walls.
- tubular medical devices have geometries with at least one inlet and at least one outlet.
- the shape of the framework 14 is chosen to provide structural support to the breachable barrier material 17 while it fully covers opening 16 .
- the shape and composition of the framework also allows the framework to be readily deformed and displaced to peripheral regions of the opening to form a permanent framed aperture.
- the particular shape of the framework illustrated in FIG. 1A, et. al., is preferred but not limiting.
- FIGS. 8B and 8C illustrate frameworks having circular configurations 70 incorporating varying numbers of peaks 76 and valleys 78 . It is also contemplated in the present invention that the distance between the peaks 76 and valleys 78 (i.e., amplitude) can be varied broadly, thereby enabling a wide range of framework geometries to be formed.
- FIGS. 9 and 10 illustrate that the framework can be in the form of an array of openings. These embodiments provide a choice of locations for the framed aperture as well as the number of framed apertures.
- FIGS. 2 A- 2 E illustrate the construct of FIGS. 1A and 1B in use.
- FIG. 2A is a perspective view of the construct as it might appear at an implantation site.
- FIG. 2B shows a guide wire 20 from a catheter, or other device, having penetrated and breached the breachable barrier material 17 .
- FIG. 2C depicts an expandable balloon catheter 22 in a deflated state being introduced through the breached barrier material into opening 16 with guide wire 20 .
- FIG. 2D illustrates inflation of the expandable balloon catheter 22 and deformation of framework 14 . As the framework 14 is deformed, opening 16 is enlarged and expanded in area.
- FIG. 2E shows the resulting permanent aperture 24 framed with altered framework 14 in implantable patch material 12 .
- FIG. 3A illustrates the present invention 15 as a component of a tubular vascular graft 30 .
- framework 14 delimiting opening 16 is fully covered by breachable barrier material 17 and incorporated into wall portion 32 of vascular graft 30 .
- breachable barrier material 17 When the invention is operated, fluid communication across wall portion 32 to luminal space 34 is established.
- FIG. 3B illustrates an embodiment of the present invention 19 having an implantable patch material 11 component.
- the implantable patch material is attached to an implantable vascular prosthesis 30 by sewing.
- Other suitable means of attaching the present invention to a wall of an implantable medical device include, but are not limited to, adhering, ultrasonic or radio frequency welding, lamination, stapling, and covering the medical device with a membrane or film to include the present invention.
- FIG. 4 illustrates an embodiment of the present invention 44 incorporated into an implantable tubular endovascular device 40 .
- the endovascular device 40 is a bifurcated design commonly used to treat aortic aneurysms and includes a main body, or trunk, portion 50 and two leg portions 52 , 54 .
- the endovascular device has a stent frame 42 and wall means 48 .
- Several fully covered framework elements of the present invention are incorporated into the wall means 48 of the stent-graft 40 .
- This embodiment of the present invention provides multiple sites for forming side branches in stent-grafts and other endovascular devices as means for providing selective perfusion and/or drainage of the implantation site.
- the framework component of the present invention is preferably incorporated into the device separately from the support elements. As shown in FIG. 4A, the framework of the present invention underlies and is discrete from the support elements of the implantable medical device.
- the location of the present invention is not limited to contact or close proximity to support elements or wall components of an implantable medical device. Indeed, the present invention can be positioned in any desired location in an implantable medical device.
- FIGS. 5 and 6 A clinical application of the embodiment illustrated in FIG. 4 is depicted in FIGS. 5 and 6.
- AAA abdominal aortic aneurysm
- AA proximal aorta
- IAs distal iliac arteries
- FIG. 6 In cases where the disease condition or aortic anatomy does not provide sufficient healthy vessel upon which to achieve device fixation at implant, it is often necessary to utilize the AA segment proximal to the RAs.
- an appropriate stent-graft 40 fixation can be achieved and effective AAA exclusion as shown in FIG. 6.
- the barrier properties of the stent-graft wall 48 occlude blood flow to the branching RA on both sides.
- one or more units 44 of the present invention are selected and utilized.
- FIGS. 7 A- 7 D The interventional procedure required to access and operate the present invention is illustrated in FIGS. 7 A- 7 D.
- a guide catheter 36 is positioned under fluoroscopic guidance to direct a guide-wire 20 toward the center of one of the plurality of available inventions 44 that is in appropriate alignment with the RA.
- the framework 14 is altered in shape to the desired aperture size using a balloon catheter 22 . Further inflation of the balloon 22 achieves the desired deformation of the framework 14 and formation of a permanent framed aperture 64 having a size appropriate for the RA. Once formed, the permanent framed aperture 64 provides for RA blood perfusion 62 in accordance with normal AA blood flow 60 .
- the present invention can be constructed of a variety of implantable materials.
- the breachable barrier material has a composition, structure, and/or thickness sufficient to at least partially bar liquids, including blood and other physiological fluids, from crossing the material, yet have sufficient structural weakness to be readily breached, perforated, or otherwise structurally disrupted with surgical instruments, or the like.
- the breachable barrier material can be made of non-biodegradable polymers, bio-degradable polymers, and elastomers, either alone or in combination. Elastomers in the breachable barrier materials can augment uncovering of the fully covered opening following breach of the barrier material.
- the breachable barrier material can be provided with filler materials that also augment breaching of the barrier material or assist in locating the invention at an implantation site.
- Suitable surgical instruments or tools for use in breaching the barrier material at an implantation site include, but are not limited to, guide-wires, Colapinto® needles, Rotablators®, and other ablation instruments utilizing radio-frequency energy, ultrasonic sound, microwave energy, or laser light.
- Suitable non-biodegradable polymers include, but are not limited to, polyester, polytetrafluoroethylene, polyamide, and polyurethane.
- the preferred material for the breachable barrier material is a porous expanded, or stretched, polytetrafluoroethylene material.
- Suitable bio-degradable polymers include, but are not limited to, materials made of polymers or copolymers possessing one or more of the following monomeric components: glycolide (glycolic acid); lactide (d-lactide, I-lactide, d,I-lactide); trimethylene carbonate; p-dioxanone; caprolactone, and hydroxybutyrate, hydroxyvalerate.
- Elastomeric materials suitable for use in the present invention include, but are not limited to, fluoroelastomers, polyurethane.
- Suitable filler materials for incorporation into the breachable barrier material include, but are not limited to, graphite, titanium oxide (TiO), barium, vitamin E, gadolinium, lossy materials, and other radio-opaque compositions.
- the breachable barrier material can be applied to the framework as a single layer or in multiple layers. When using multiple layers of breachable barrier material, it is preferred to orient the individual layers in different directions (see e.g. FIG. 11).
- the framework is made of materials that are capable of supporting the breachable barrier material while the barrier material is fully covering the opening delimited by the framework.
- the materials of the framework permit the framework to be readily shaped, reshaped, or otherwise altered in configuration while the invention is located at an implantation site.
- the framework can be made of malleable materials, plastically deformable materials, and/or self-expanding (i.e., super-elastic) metals or polymers. When materials are used that do not lend themselves to visualization with fluoroscopy, x-ray imagining, magnetic resonance imaging, etc., radio-opaque or other imaging compounds can be introduced into the framework materials.
- the materials of the framework also need to be sufficiently resilient to provide permanent reinforcement of peripheral regions of the aperture under physiological conditions.
- the framework component can serve as anchoring means for other medical devices 90 attached thereto (e.g., FIG. 7E).
- Suitable materials for the framework include, but are not limited to, implantable metals such as gold, silver, tantalum, tungsten, and chromium, implantable metal alloys such as stainless steel, nitinol metal, and implantable polymers such as polyurethanes, fluorinated ethylene propylene, and polytetrafluoroethylene.
- the framework can be made by molding, casting, laser cutting and/or laser machining, stamping, photo-etching, wire-forming, electrical discharge machining (EDM), bent wire techniques, or other suitable fabrication method.
- any implantable material can be used for the component.
- Suitable materials include but are not limited to, implantable metals, implantable metal alloys, implantable polymers such as polyester (Dacron®), polyamide (Nylon), polytetrafluoroethylene, silicone, and polyurethane.
- the present invention can be constructed in a variety of ways.
- the invention can be made by attaching the breachable barrier material to the framework material with adhesives, heat, pressure, and/or ultrasonic welding.
- the breachable barrier material can be attached to an implantable medical device with similar methodologies.
- the invention can also be incorporated into an implantable medical device by molding, sewing, wrapping with a film or membrane, and/or mechanical fixation.
- An implantable medical device made of an expanded polytetrafluoroethylene (ePTFE) in the form of a tube or sheet can be supplied with an embodiment of the present invention by first cutting a hole in the ePTFE slightly smaller than the largest diameter of the framework component. Next, a powder coating of fluorinated ethylene propylene (FEP) is applied to both sides of the framework material and the framework material placed over the hole in the ePTFE material. A suitably sized piece of breachable barrier material is placed over the framework component. Heat and pressure are applied to the combination to attach the materials together.
- FEP fluorinated ethylene propylene
- Another method of attaching the present invention to an implantable medical device involves applying an adhesive material, such a room temperature vulcanizing (RTV) silicone, to both sides of the framework material and pressing one side of the framework onto a wall of the medical device having a suitably sized hole formed therein. A suitable breachable barrier material is then pressed onto the other adhesive-coated side of the framework component. Any excess barrier material is trimmed away from the framework to complete the installation.
- an adhesive material such as a room temperature vulcanizing (RTV) silicone
- Yet another method of attaching the present invention to an implantable medical device involves placing a framework component over a suitably sized hole in a wall of the medical device and wrapping one or more layers of a biocompatible film over the framework component.
- the wrapped film layer(s) can also serve as the breachable barrier material.
- the film wrapping material can be further secured by heating the construction.
- the present invention can be attached to the medical device in such a way that the opening is accessibly through holes in the meshwork.
- an adhesive-coated framework material is placed on a breachable barrier material. Additional adhesive is placed on perimeter regions of the barrier material.
- a meshwork device is placed over this combination so the opening of the present invention is accessible through one or more holes in the meshwork. Pressure is applied to the construct to adhere the components together.
- a preferred implantable medical device is a woven mesh material commercially available from Davol, Inc. under the trade name Bard® MarlexTM Mesh—Monofilament Knitted Polypropylene (Catalog No. 011265).
- a planar sheet embodiment of the present invention approximately 8.3 cm (3.25′′) by 13.3 cm (5.25′′), was constructed as follows.
- a first layer of an expanded polytetrafluoroethylene (ePTFE) sheet material having a thickness of about 0.4 mm was obtained from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. under the tradename GORE-TEX® Cardiovascular Patch as part number 1800610004 (FIG. 12, part A 1 ).
- ePTFE expanded polytetrafluoroethylene
- a second layer of a fluoro-elastomeric sheet material composed of a thermoplastic copolymer of tetrafluoroethylene (TFE) and perfluoro(methyl vinyl ether) (PMVE) was constructed by compression molding the crumb form of the copolymer at a temperature of about 250° C. to form a sheet about 0.2 mm (0.008′′) in thickness (FIG. 12, part A 3 ).
- TFE tetrafluoroethylene
- PMVE perfluoro(methyl vinyl ether)
- a third layer of sheet material (FIG. 12, part A 4 ) is composed of ePTFE made according to U.S. Pat. No. 4,482,516, issued to Gore.
- the sheet material was approximately 0.17 mm thick with an average fibril length of greater than about 10 microns.
- a sheet of medical grade 316 stainless steel was obtained from Laserage Technologies, Inc., Waukegan, Ill. for use in constructing a framework.
- the framework was laser machined into an undulating pattern having a continuous, generally circular, ringed configuration (FIG. 12, part A 2 ).
- the thickness of the framework was about 0.4 mm (0.016′′).
- the minimum distance between individual framework elements located opposite one another in the opening delimited by the framework was about 0.2 mm (0.008′′).
- FIG. 12 Components 100 , 102 , 103 , and 104 were placed between layers of high temperature padding material and aluminum plates (FIG. 12, parts 105 , 106 ).
- the aluminum plates were approximately 15.2 cm (6′′) square and 0.062′′ thick.
- the high temperature padding material 105 was made of GORE-TEX® Soft Tissue Patch having a thickness of about 2 mm (0.079′′) available from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. as part number 1310015020.
- the assembly was placed in a heated Carver press and laminated together in the arrangement shown in FIG. 12 for about 5 minutes, at about 200° C. with a pressure of about 0.5 Mpa (80 lb/in 2 ). Following the compression cycle in the press, the padding material was discarded.
- a 4 mm hole was then cut though all three layers of material at the center point of the reinforcement element using a 4 mm sharpened coring punch.
- a layer of discontinuous fluorinated ethylene propylene (FEP) coating was placed between each layer of ePTFE material. These combined materials were placed over the cutout hole and secured in place using a heated soldering iron applied around the outer perimeter of the cutout hole. Excess film material was than trimmed from the final assembly and the edges tacked down thoroughly with the heated soldering iron. The resulting article is shown in FIG. 13.
- This example describes a tubular vascular graft having the article of Example 1 incorporated into the wall of the tubular graft.
- the article of Example 1 was trimmed and sewn into a corresponding hole cut through the wall of an ePTFE vascular graft.
- the ePTFE vascular graft was a GORE-TEX® Vascular Graft available from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. as part number SA1604.
- the article from Example 1 was sewn into the corresponding hole of the tubular construct with an ePTFE suture material obtained from Medical Products Division of W. L. Gore & Associates, Inc. Flagstaff, Ariz. under the tradename GORE-TEX® Suture as part number CV-5.
- the resulting article is shown in FIG. 3B.
Abstract
Description
- The present invention relates to implantable medical devices. More particularly, the invention relates to means for forming a framed aperture in wall portions, or other partitions, of implantable medical devices to establish and maintain fluid communication across the wall portion of the medical device. The present invention also relates to methods of making the invention.
- Abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs) are diagnosed in approximately 250,000 and 20,000 patients respectively each year. Left untreated, these aneurysms commonly progress to rupture resulting in death. Prior to the advent of interventional catheter-based techniques, conventional surgical treatment has been the method of treatment for these lesions. Due to the often emergent condition of these patients and the potential for significant blood loss, high morbidity and mortality rates have been associated with this type of surgery.
- With the introduction of catheter-based interventional techniques, new non-surgical therapies were made available to many patients. Since the initial animal work performed by Schatz et. al., small metallic tubes (i.e., stents) have been found to be of significant benefit for patients with coronary artery and peripheral artery disease. Schatz, R. A., Palmaz, J. C., Tio, F. O., Garcia, F., Garcia, O., Reuter, S. R. “Balloon-expandable intracoronary stents in the adult dog.”Circulation 76:450-7 (1987). In an effort to treat abdominal aortic aneurysms, Parodi et. al. reported on their experience with combining the barrier properties of synthetic vascular grafts with stent technology (i.e., stent-graft) to effectively inhibit blood flow into the aneurysm sac using catheter delivery systems. Parodi, J. C., Palmaz, J. C., Barone, H. D. “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms.” Ann. Vasc. Surg 5:491-9 (1991).
- This technology has continued to progress with significant improvements in successful device deployment and improved patient outcomes. Despite these improvements, there are many patients for which this technology is not applicable as a result of unique anatomical or disease conditions. Specifically, in the case of AAA disease, stent-graft devices typically require some amount of healthy vessel both proximal and distal to the aneurysm sac into which to place the stent-graft. In many patients, the proximal vessel is not long enough to achieve adequate fixation. Placement of the stent-graft in a more proximal location in these patients in order to achieve adequate fixation could partially or completely occlude the renal arteries providing blood to the kidneys. A number of different device designs have been proposed to allow device fixation to the aortic vessel proximal to the renal arteries (i.e., suprarenal fixation). Widespread applicability of supra-renal fixation devices has been limited by the flexibility of these designs, morphological variation of aneurysmal neck geometry across patients, and the coverage of the renal ostia with metallic stents which can act as a nidus for thromo-embolism of the renal circulation and/or hinder subsequent interventional access to this vasculature.
- A similar situation exists for TAA disease. These aneurysmal lesions are often located in close proximity to the subclavian and carotid arterial branches. When inadequate proximal vascular tissue is available for anchoring the endoprosthesis, a suitable proximal anchoring zone can be created by performing a surgical transposition prior to the interventional procedure. This surgical approach is intended to assure continued flow to all vessels. Alternative means for achieving side-branch perfusion through the wall of a stent-graft are therefore desirable.
- Other clinical conditions where there would be a benefit for fluid communication through the wall of a prosthesis are those involving cardiac surgery. Arterial blood leaving the heart serves to carry oxygen to the body. In contrast, venous blood is returned to the heart via the superior and inferior vena cava after releasing oxygen to the body and absorbing carbon dioxide and other waste products. Approximately 40,000 children are born each year with congenital heart defects. These abnormalities often involve a single functional ventricle and defects in the tissues (i.e., septum) separating the right (venous) and left (arterial) side of the heart. Mixing of arterial and venous blood in these patients results in reduced oxygen carrying capacity and often shortened life expectancies.
- Cardiac surgical interventions performed for the most complex congenital heart abnormalities often require multiple surgical procedures to effect the final treatment for the patient. The Fontan procedure is an example of a staged surgical treatment that is designed to overcome these significant structural heart abnormalities and isolate systemic and pulmonary circulation at the definitive treatment. “Correction de I'atresie tricuspidienne.” Fontan, F., Mounicot, F. B., Baudet, E., Simonneau, J, Gordo, J., Gouffrant, J. M. Rapport de deux cas “corriges” par I'utilisation d'une technique chirurgicale nouvelle. [“Correction” of tricuspid atresia. 2 cases “corrected” using a new surgical technic]Ann-Chir-Thorac-Cardiovasc 10:39-47 (1971). Annecchino, F. P., Fontan, F., Chauve, A., Quaegebeur, J. “Palliative reconstruction of the right ventricular outflow tract in tricuspid atresia: a report of 5 patients.” Ann-Thorac-Surg.29:317-21 (1980). Ottenkamp, J., Rohmer, J., Quaegebeur, J. M., Brom, A. G., Fontan, F. “Nine years' experience of physiological correction of tricuspid atresia: long-term results and current surgical approach.” Thorax 37:718-26 (1982). The surgical procedures must be staged to minimize the pressure and volume loads on the remaining functional single ventricle. In the first stage procedure, a connection is created between the Superior Vena Cava (SVC) and the Pulmonary Artery (PA). This is referred to as a Hemi-Fontan or Glenn Shunt procedure. Mathur, M., Glenn, W. W. “Rational approach to the surgical management of tricuspid atresia.” Circulation 37:1162-7 (1968). This shunt reduces the degree of venous and arterial blood mixing, and improves oxygenation of the blood.
- Once the pulmonary circulation and functional ventricle are sufficiently developed, a subsequent procedure is performed wherein the blood going to the right ventricle is bypassed, by routing the blood in the Inferior Vena Cava (IVC) directly to the PA by way of a baffle or tube connecting the IVC to the PA. At the time of this procedure, a small hole is typically created in the side of the connection tube to allow some flow of blood into the right ventricle. This small hole is considered a temporary connection that reduces the work for the remaining ventricle when pulmonary vascular resistance is elevated. Bridges, N. D., Mayer, J. E., Lock, J. E., Jonas, R. A., Hanley, F. L., Keane, J. F., Perry, S. B., Castaneda, A. R. “Effect of baffle fenestration on outcome of the modified Fontan operation.”Circulation 86:1762-9 (1992).
- The final surgical procedure involves either surgical closure or transcatheter occlusion of the temporary hole in the IVC to PA connector tube. This multi-staged conventional surgical approach for patients with complex congenital heart disease is not optimal as it puts patients at additional risk of morbidity and mortality with each subsequent surgical intervention. This risk may be reduced if the first surgical intervention can set the stage for a future minimally invasive procedure that eliminates the need for additional open-heart surgery.
- Various devices and design modifications have been proposed in an effort to provide access to anatomical structures surrounding the device or to internal spaces of the device.
- U.S. Pat. No. 6,428,565, issued to Wisselink, and U.S. Pat. No. 6,395,018, issued to Castaneda, each relate to stent-graft systems with pre-formed apertures to allow for side-branch access. Neither of these devices have apertures that are closed at the time of initial implant.
- U.S. Pat. No. 6,398,803, issued to Layne, et. al., relates to partially covered stents having various patterns of open apertures along the length of the device. As with the Wisselink and Castaneda devices, the apertures are fully formed prior to deployment of the device.
- U.S. Pat. No. 6,432,127, issued to Kim, et. al., discloses formation of an aperture in the wall of a vascular conduit through the use of a cutting tool. The conduit does not provide a deformable framework encompassing the aperture formation site. As a result, targeting the precise location of the region in which to create the aperture is difficult to visualize using conventional imaging techniques. Moreover, the aperture is not reinforced along its peripheral regions once the aperture is formed. The absence of a framework delimiting the aperture formation site precludes precise sizing of the aperture during its formation.
- There remains a need for a device that initially maintains the continuity and fluid-retaining properties of a wall portion of an implantable medical device, while providing means for forming a permanent aperture in the medical device. Such a device would permit custom sizing of the aperture in situ at the implant site during surgery.
- The present invention is directed to a device that is amenable to transmural fenestration. In particular, the present invention permits a permanent framed aperture to be formed in a wall, or similar partition, of implantable medical devices as a means for establishing and maintaining fluid communication across the wall of the medical device following implantation. The present invention provides a breachable barrier material that initially maintains the continuity and any fluid-retaining properties of the wall of the medical device. The breachable barrier material fully covers an opening delimited by a framework. In use, the breachable barrier material is breached with a surgical instrument and the shape of the framework altered to enlarge, or otherwise alter, the area of the opening. In the process, the opening becomes uncovered and accessible to flow of fluid through the opening. The altered framework provides structural reinforcement to peripheral regions (e.g., circumferential) of the enlarged opening and forms a permanent aperture in the wall of the medical device. The altered framework can also be used to provide a secure anchoring site for ancillary medical devices. The permanent aperture can be formed in the wall of the implantable medical device at the time of surgical or catheter-based intervention or at a later date through the use of interventional or surgical techniques.
- The present invention is particularly suited for use with vascular prostheses, and other implantable medical devices providing fluid containment or fluid partitioning, that can benefit from the formation of one or more permanent apertures in the devices at the implantation site. With stent-grafts spanning an aneurysm, for example, the invention can provide a framed aperture in the wall of the stent-graft for side-branches or drainage sites. Vascular grafts can be bypassed or bifurcated in-situ with the present invention. The invention can also be used with surgically implanted cardiovascular patches to provide perfusion or other access to the heart and vascular system.
- The present invention can be added to an implantable medical device following its construction, or included in the manufacture of the device as an integral component. The breachable barrier material of the present invention is made of implantable polymers that are readily breached, perforated, or otherwise structurally disrupted with surgical instruments. The breachable barrier material can also be made of polymers that are structurally disrupted through degradation and absorption by the body of the implant recipient. The polymers of the breachable barrier material can be incorporated with filler materials to assist in breaching the barrier material or to facilitate visualization of the aperture region in an implant recipient.
- The framework is made of implantable metallic or polymeric materials that can be altered in shape. These framework materials can be deformed or otherwise altered in shape with surgical instruments or have shape-memory properties that permit the framework to assume different shapes without the use of an instrument. The framework materials are shaped in various ways to assist in the combined roles of structurally reinforcing the breachable barrier material and the opening, being capable of reconfiguration, and providing a permanent framed aperture.
- In one surgical method, an implantable medical device utilizing the present invention is placed at a surgical site with conventional or interventional surgical techniques. Once the correct position of the medical device is confirmed, a catheter guide-wire, or other surgical instrument, is used to breach the breachable barrier material and begin to uncover the covered opening. An expandable balloon catheter in a deflated configuration is then inserted into the partially uncovered opening and inflated. As the balloon catheter is inflated, it expands in diameter, altering the shape of the framework and displacing the remaining barrier material from the area of the opening. When the framework has been reconfigured as desired, the balloon catheter is deflated and removed from the opening. This leaves a permanent framed aperture in the wall of the medical device. The permanent aperture can provide immediate therapies and surgical remedies, such as branch vessel perfusion, or co-operate with other medical devices.
- In one embodiment, the present invention is an implantable medical device comprising a framework delimiting an opening having a first area and a breachable barrier material fully covering said opening, wherein a permanent aperture having a second area is formed following breach of said breachable material and said framework is adaptable to be altered in shape.
- In another embodiment, the present invention is an implantable medical device comprising a continuous wall, at least one framework in said wall delimiting an opening having a first area, a breachable barrier material fully covering said opening, wherein a permanent aperture having a second area is formed following breach of said breachable material and said framework is adaptable to be altered in shape and have a reinforced peripheral region in said continuous wall.
- Further aspects and advantages of the present invention will be apparent to those skilled in the art after reading and understanding the detailed description of preferred embodiments set forth hereinbelow and after viewing the accompanying drawings.
- The foregoing summary, as well as the following detailed description of a preferred embodiment of the invention, will be better understood when read in conjunction with the appended drawings. For purposes of illustrating the invention, there is shown in the drawings an embodiment that is presently preferred. It should be understood, however, that the invention is not limited to the precise arrangement and instrumentality shown. In the drawings:
- FIG. 1A illustrates a top view of the present invention.
- FIGS.1B-1D illustrate a side view of the present invention.
- FIGS.2A-2E illustrate the present invention in operation.
- FIG. 3A illustrates an embodiment of the present invention incorporated into a wall of a tubular medical device.
- FIG. 3B illustrates an embodiment of the present invention incorporated into a planar material that is attached to a wall of a tubular medical device.
- FIG. 4 illustrates an embodiment of the present invention incorporated into a medical device.
- FIG. 4A illustrates an embodiment of the present invention placed in a discrete location relative to scaffolding and wall elements of an implantable medical device.
- FIG. 5 illustrates an abdominal aortic aneurysm.
- FIG. 6 illustrates a stent-graft incorporating an embodiment of the present invention placed in the region of an abdominal aortic aneurysm.
- FIGS.7A-7D illustrate the present invention being utilized to provide perfusion to side branches of a blood vessel.
- FIG. 7E illustrates an embodiment of the present invention serving as attachment means for another medical device.
- FIGS.8A-8C illustrate the framework component of the present invention in various non-limiting shapes.
- FIG. 9 illustrates the framework component of the present invention in the form of an array.
- FIG. 10 illustrates the framework component of the present invention in the form of an array.
- FIG. 11 illustrates a method of constructing the breachable barrier material in an embodiment of the present invention.
- FIG. 12 is an exploded view of an embodiment of the present invention under construction.
- FIG. 13 is a perspective view of an embodiment of the present invention.
- The accompanying diagrams include various anatomical structures and associated clinical pathologies that are identified as follows:
- AA=Abdominal Aorta
- RA=Renal Artery
- IA=Iliac Artery
- AAA=Abdominal Aortic Aneurysm
- The present invention can be used in combination with a variety of implantable fluid-containing medical devices to establish fluid communication across a wall, or other partition, in the devices. In many situations, the present invention is employed at the time the medical device is implanted. In other instances, the present invention is accessed and utilized after the medical device has been implanted for a period of time. The present invention can also be used before the implant procedure begins.
- FIG. 1A is a top view of an embodiment of the
present invention 10 incorporated into animplantable patch material 12. FIG. 1B is a side view of this embodiment generally illustrating the relationship of the components. In this embodiment, aframework 14 is surrounded by a layer of implantablepolymeric material 18. Theframework 14 delimits anopening 16 that is fully covered with abreachable barrier material 17. Thepolymer layer 18 is sandwiched between two layers ofimplantable patch material framework 14, opening 16, andbreachable barrier material 17 of the present invention. In similar embodiments of the present invention, the implantable patch material or other wall components are considered part of the invention. In addition to implantable medical devices having planar configurations, implantable medical devices having tubular configurations are also suitable for use with the present invention. Tubular medical devices are generally cylindrical in shape and not confined to having parallel walls. In addition, tubular medical devices have geometries with at least one inlet and at least one outlet. - The shape of the
framework 14 is chosen to provide structural support to thebreachable barrier material 17 while it fully coversopening 16. The shape and composition of the framework also allows the framework to be readily deformed and displaced to peripheral regions of the opening to form a permanent framed aperture. The particular shape of the framework illustrated in FIG. 1A, et. al., is preferred but not limiting. For example, FIGS. 8B and 8C illustrate frameworks havingcircular configurations 70 incorporating varying numbers ofpeaks 76 andvalleys 78. It is also contemplated in the present invention that the distance between thepeaks 76 and valleys 78 (i.e., amplitude) can be varied broadly, thereby enabling a wide range of framework geometries to be formed. In addition to enhancing support for the breachable barrier material with these framework designs, a wide range of aperture sizes can be achieved with these designs. Supporting leg struts 74 can also be incorporated into the framework design to enhance attachment to surrounding wall materials. Othernon-circular configurations 79 of theframework 14 are also contemplated. Furthermore, FIGS. 9 and 10 illustrate that the framework can be in the form of an array of openings. These embodiments provide a choice of locations for the framed aperture as well as the number of framed apertures. - FIGS.2A-2E illustrate the construct of FIGS. 1A and 1B in use. FIG. 2A is a perspective view of the construct as it might appear at an implantation site. FIG. 2B shows a
guide wire 20 from a catheter, or other device, having penetrated and breached thebreachable barrier material 17. FIG. 2C depicts anexpandable balloon catheter 22 in a deflated state being introduced through the breached barrier material into opening 16 withguide wire 20. FIG. 2D illustrates inflation of theexpandable balloon catheter 22 and deformation offramework 14. As theframework 14 is deformed, opening 16 is enlarged and expanded in area. Following deflation and removal of the balloon catheter, FIG. 2E shows the resultingpermanent aperture 24 framed with alteredframework 14 inimplantable patch material 12. - FIG. 3A illustrates the
present invention 15 as a component of a tubularvascular graft 30. In this embodiment,framework 14 delimitingopening 16 is fully covered bybreachable barrier material 17 and incorporated intowall portion 32 ofvascular graft 30. When the invention is operated, fluid communication acrosswall portion 32 toluminal space 34 is established. - FIG. 3B illustrates an embodiment of the
present invention 19 having an implantable patch material 11 component. The implantable patch material is attached to an implantablevascular prosthesis 30 by sewing. Other suitable means of attaching the present invention to a wall of an implantable medical device include, but are not limited to, adhering, ultrasonic or radio frequency welding, lamination, stapling, and covering the medical device with a membrane or film to include the present invention. - FIG. 4 illustrates an embodiment of the
present invention 44 incorporated into an implantable tubularendovascular device 40. In this embodiment, theendovascular device 40 is a bifurcated design commonly used to treat aortic aneurysms and includes a main body, or trunk,portion 50 and twoleg portions stent frame 42 and wall means 48. Several fully covered framework elements of the present invention are incorporated into the wall means 48 of the stent-graft 40. As seen in FIG. 4, there is a longitudinal displacement between the present invention and the support elements (i.e., scaffolding) of the stent-graft. This embodiment of the present invention provides multiple sites for forming side branches in stent-grafts and other endovascular devices as means for providing selective perfusion and/or drainage of the implantation site. - In embodiments of the present invention used in combination with stent-grafts, and other implantable medical devices utilizing support elements (i.e., scaffolding), the framework component of the present invention is preferably incorporated into the device separately from the support elements. As shown in FIG. 4A, the framework of the present invention underlies and is discrete from the support elements of the implantable medical device. The location of the present invention is not limited to contact or close proximity to support elements or wall components of an implantable medical device. Indeed, the present invention can be positioned in any desired location in an implantable medical device.
- A clinical application of the embodiment illustrated in FIG. 4 is depicted in FIGS. 5 and 6. A typical abdominal aortic aneurysm (AAA) is shown in FIG. 5 with the proximal aorta (AA) leading to renal artery (RA) branches and distal iliac arteries (IAs). In cases where the disease condition or aortic anatomy does not provide sufficient healthy vessel upon which to achieve device fixation at implant, it is often necessary to utilize the AA segment proximal to the RAs. In this suprarenal implant position, an appropriate stent-
graft 40 fixation can be achieved and effective AAA exclusion as shown in FIG. 6. In this configuration however, the barrier properties of the stent-graft wall 48 occlude blood flow to the branching RA on both sides. In order to achieve RA perfusion, one ormore units 44 of the present invention are selected and utilized. - The interventional procedure required to access and operate the present invention is illustrated in FIGS.7A-7D. Following deployment of
stent graft 40, aguide catheter 36 is positioned under fluoroscopic guidance to direct a guide-wire 20 toward the center of one of the plurality ofavailable inventions 44 that is in appropriate alignment with the RA. Following guide-wire 20 breach of thebreachable barrier material 16, theframework 14 is altered in shape to the desired aperture size using aballoon catheter 22. Further inflation of theballoon 22 achieves the desired deformation of theframework 14 and formation of a permanent framedaperture 64 having a size appropriate for the RA. Once formed, the permanent framedaperture 64 provides forRA blood perfusion 62 in accordance with normalAA blood flow 60. - The present invention can be constructed of a variety of implantable materials. The breachable barrier material has a composition, structure, and/or thickness sufficient to at least partially bar liquids, including blood and other physiological fluids, from crossing the material, yet have sufficient structural weakness to be readily breached, perforated, or otherwise structurally disrupted with surgical instruments, or the like. The breachable barrier material can be made of non-biodegradable polymers, bio-degradable polymers, and elastomers, either alone or in combination. Elastomers in the breachable barrier materials can augment uncovering of the fully covered opening following breach of the barrier material. The breachable barrier material can be provided with filler materials that also augment breaching of the barrier material or assist in locating the invention at an implantation site.
- Suitable surgical instruments or tools for use in breaching the barrier material at an implantation site include, but are not limited to, guide-wires, Colapinto® needles, Rotablators®, and other ablation instruments utilizing radio-frequency energy, ultrasonic sound, microwave energy, or laser light.
- Suitable non-biodegradable polymers include, but are not limited to, polyester, polytetrafluoroethylene, polyamide, and polyurethane. The preferred material for the breachable barrier material is a porous expanded, or stretched, polytetrafluoroethylene material. Suitable bio-degradable polymers include, but are not limited to, materials made of polymers or copolymers possessing one or more of the following monomeric components: glycolide (glycolic acid); lactide (d-lactide, I-lactide, d,I-lactide); trimethylene carbonate; p-dioxanone; caprolactone, and hydroxybutyrate, hydroxyvalerate. Elastomeric materials suitable for use in the present invention include, but are not limited to, fluoroelastomers, polyurethane. Suitable filler materials for incorporation into the breachable barrier material include, but are not limited to, graphite, titanium oxide (TiO), barium, vitamin E, gadolinium, lossy materials, and other radio-opaque compositions.
- The breachable barrier material can be applied to the framework as a single layer or in multiple layers. When using multiple layers of breachable barrier material, it is preferred to orient the individual layers in different directions (see e.g. FIG. 11).
- The framework is made of materials that are capable of supporting the breachable barrier material while the barrier material is fully covering the opening delimited by the framework. The materials of the framework permit the framework to be readily shaped, reshaped, or otherwise altered in configuration while the invention is located at an implantation site. The framework can be made of malleable materials, plastically deformable materials, and/or self-expanding (i.e., super-elastic) metals or polymers. When materials are used that do not lend themselves to visualization with fluoroscopy, x-ray imagining, magnetic resonance imaging, etc., radio-opaque or other imaging compounds can be introduced into the framework materials.
- The materials of the framework also need to be sufficiently resilient to provide permanent reinforcement of peripheral regions of the aperture under physiological conditions. In addition to providing structural support to peripheral regions of the aperture portion of the invention, the framework component can serve as anchoring means for other
medical devices 90 attached thereto (e.g., FIG. 7E). - Suitable materials for the framework include, but are not limited to, implantable metals such as gold, silver, tantalum, tungsten, and chromium, implantable metal alloys such as stainless steel, nitinol metal, and implantable polymers such as polyurethanes, fluorinated ethylene propylene, and polytetrafluoroethylene. The framework can be made by molding, casting, laser cutting and/or laser machining, stamping, photo-etching, wire-forming, electrical discharge machining (EDM), bent wire techniques, or other suitable fabrication method.
- In embodiments of the present invention that include a patch, tube, or other walled component, essentially any implantable material can be used for the component. Suitable materials include but are not limited to, implantable metals, implantable metal alloys, implantable polymers such as polyester (Dacron®), polyamide (Nylon), polytetrafluoroethylene, silicone, and polyurethane.
- The present invention can be constructed in a variety of ways. The invention can be made by attaching the breachable barrier material to the framework material with adhesives, heat, pressure, and/or ultrasonic welding. In turn, the breachable barrier material can be attached to an implantable medical device with similar methodologies. The invention can also be incorporated into an implantable medical device by molding, sewing, wrapping with a film or membrane, and/or mechanical fixation.
- An implantable medical device made of an expanded polytetrafluoroethylene (ePTFE) in the form of a tube or sheet can be supplied with an embodiment of the present invention by first cutting a hole in the ePTFE slightly smaller than the largest diameter of the framework component. Next, a powder coating of fluorinated ethylene propylene (FEP) is applied to both sides of the framework material and the framework material placed over the hole in the ePTFE material. A suitably sized piece of breachable barrier material is placed over the framework component. Heat and pressure are applied to the combination to attach the materials together.
- Another method of attaching the present invention to an implantable medical device involves applying an adhesive material, such a room temperature vulcanizing (RTV) silicone, to both sides of the framework material and pressing one side of the framework onto a wall of the medical device having a suitably sized hole formed therein. A suitable breachable barrier material is then pressed onto the other adhesive-coated side of the framework component. Any excess barrier material is trimmed away from the framework to complete the installation.
- Yet another method of attaching the present invention to an implantable medical device involves placing a framework component over a suitably sized hole in a wall of the medical device and wrapping one or more layers of a biocompatible film over the framework component. In this embodiment, the wrapped film layer(s) can also serve as the breachable barrier material. The film wrapping material can be further secured by heating the construction.
- For implantable medical devices having a wall element in the form of a meshwork, the present invention can be attached to the medical device in such a way that the opening is accessibly through holes in the meshwork. In this embodiment, an adhesive-coated framework material is placed on a breachable barrier material. Additional adhesive is placed on perimeter regions of the barrier material. A meshwork device is placed over this combination so the opening of the present invention is accessible through one or more holes in the meshwork. Pressure is applied to the construct to adhere the components together. A preferred implantable medical device is a woven mesh material commercially available from Davol, Inc. under the trade name Bard® Marlex™ Mesh—Monofilament Knitted Polypropylene (Catalog No. 011265).
- These construction methodologies are exemplary and are not intended to limit the scope of the present invention.
- Without intending to limit the scope of the present invention, the apparatus and method of production of the present invention may be better understood by referring to the following examples.
- A planar sheet embodiment of the present invention, approximately 8.3 cm (3.25″) by 13.3 cm (5.25″), was constructed as follows. A first layer of an expanded polytetrafluoroethylene (ePTFE) sheet material having a thickness of about 0.4 mm was obtained from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. under the tradename GORE-TEX® Cardiovascular Patch as part number 1800610004 (FIG. 12, part A1).
- A second layer of a fluoro-elastomeric sheet material composed of a thermoplastic copolymer of tetrafluoroethylene (TFE) and perfluoro(methyl vinyl ether) (PMVE) was constructed by compression molding the crumb form of the copolymer at a temperature of about 250° C. to form a sheet about 0.2 mm (0.008″) in thickness (FIG. 12, part A3). The resulting material had the attributes described in TABLE 1 below.
- A third layer of sheet material (FIG. 12, part A4) is composed of ePTFE made according to U.S. Pat. No. 4,482,516, issued to Gore. The sheet material was approximately 0.17 mm thick with an average fibril length of greater than about 10 microns.
- A sheet of medical grade 316 stainless steel was obtained from Laserage Technologies, Inc., Waukegan, Ill. for use in constructing a framework. The framework was laser machined into an undulating pattern having a continuous, generally circular, ringed configuration (FIG. 12, part A2). The thickness of the framework was about 0.4 mm (0.016″). The minimum distance between individual framework elements located opposite one another in the opening delimited by the framework was about 0.2 mm (0.008″).
- These four components were aligned together as shown in FIG. 12.
Components parts 105, 106). The aluminum plates were approximately 15.2 cm (6″) square and 0.062″ thick. The hightemperature padding material 105 was made of GORE-TEX® Soft Tissue Patch having a thickness of about 2 mm (0.079″) available from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. as part number 1310015020. The assembly was placed in a heated Carver press and laminated together in the arrangement shown in FIG. 12 for about 5 minutes, at about 200° C. with a pressure of about 0.5 Mpa (80 lb/in2). Following the compression cycle in the press, the padding material was discarded. - A 4 mm hole was then cut though all three layers of material at the center point of the reinforcement element using a 4 mm sharpened coring punch. Four layers of high strength ePTFE film made according to U.S. Pat. No. 5,476,589, issued to Bacino, were obtained and oriented at 90 degree angles with respect to one another (Figure C). A layer of discontinuous fluorinated ethylene propylene (FEP) coating was placed between each layer of ePTFE material. These combined materials were placed over the cutout hole and secured in place using a heated soldering iron applied around the outer perimeter of the cutout hole. Excess film material was than trimmed from the final assembly and the edges tacked down thoroughly with the heated soldering iron. The resulting article is shown in FIG. 13.
TABLE 1 Characteristic Target PMVE wt % about 60% TFE wt % About 40% 100% Secant Modulus* About 2.1-2.2 MPa Softening Temperature <275° C. Thermal Degradation Temp. >300° C. Melt Flow Index** >2.0 Durometer 60-80 Shore A - This example describes a tubular vascular graft having the article of Example 1 incorporated into the wall of the tubular graft. The article of Example 1 was trimmed and sewn into a corresponding hole cut through the wall of an ePTFE vascular graft. The ePTFE vascular graft was a GORE-TEX® Vascular Graft available from the Medical Products Division of W. L. Gore & Associates, Inc., Flagstaff, Ariz. as part number SA1604. The article from Example 1 was sewn into the corresponding hole of the tubular construct with an ePTFE suture material obtained from Medical Products Division of W. L. Gore & Associates, Inc. Flagstaff, Ariz. under the tradename GORE-TEX® Suture as part number CV-5. The resulting article is shown in FIG. 3B.
- Accurate and illustrative examples of the invention have been described in detail however, it is readily foreseen that numerous modifications may be made to these examples without departing from the nature and spirit or scope of the present invention.
Claims (33)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/251,031 US20040059406A1 (en) | 2002-09-20 | 2002-09-20 | Medical device amenable to fenestration |
PCT/US2003/029200 WO2004026181A1 (en) | 2002-09-20 | 2003-09-16 | Medical device amenable to fenestration |
CA002498176A CA2498176C (en) | 2002-09-20 | 2003-09-16 | Medical device amenable to fenestration |
JP2004537900A JP4571498B2 (en) | 2002-09-20 | 2003-09-16 | Medical device capable of opening |
AT03754655T ATE311834T1 (en) | 2002-09-20 | 2003-09-16 | MEDICAL DEVICE WITH WINDOW |
AU2003272473A AU2003272473B2 (en) | 2002-09-20 | 2003-09-16 | Medical device amenable to fenestration |
EP03754655A EP1539037B1 (en) | 2002-09-20 | 2003-09-16 | Medical device amenable to fenestration |
DE60302674T DE60302674T2 (en) | 2002-09-20 | 2003-09-16 | MEDICAL DEVICE WITH WINDOW |
US13/955,899 US9694108B2 (en) | 2002-09-20 | 2013-07-31 | Medical device ameneable to fenestration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/251,031 US20040059406A1 (en) | 2002-09-20 | 2002-09-20 | Medical device amenable to fenestration |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/955,899 Continuation US9694108B2 (en) | 2002-09-20 | 2013-07-31 | Medical device ameneable to fenestration |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040059406A1 true US20040059406A1 (en) | 2004-03-25 |
Family
ID=31992633
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/251,031 Abandoned US20040059406A1 (en) | 2002-09-20 | 2002-09-20 | Medical device amenable to fenestration |
US13/955,899 Expired - Lifetime US9694108B2 (en) | 2002-09-20 | 2013-07-31 | Medical device ameneable to fenestration |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/955,899 Expired - Lifetime US9694108B2 (en) | 2002-09-20 | 2013-07-31 | Medical device ameneable to fenestration |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040059406A1 (en) |
EP (1) | EP1539037B1 (en) |
JP (1) | JP4571498B2 (en) |
AT (1) | ATE311834T1 (en) |
AU (1) | AU2003272473B2 (en) |
CA (1) | CA2498176C (en) |
DE (1) | DE60302674T2 (en) |
WO (1) | WO2004026181A1 (en) |
Cited By (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030195606A1 (en) * | 1999-09-23 | 2003-10-16 | Advanced Stent Technologies, Inc., A Delaware Corporation | Bifurcation stent system and method |
US20040117860A1 (en) * | 2002-09-19 | 2004-06-17 | Lg Electronics Inc. | Multicast service providing method in mobile communication system |
US20040127973A1 (en) * | 2002-11-05 | 2004-07-01 | Mangiardi Eric K. | Removable biliary stent |
US20040127974A1 (en) * | 2002-11-05 | 2004-07-01 | Mangiardi Eric K. | Differential covering and coating methods |
US20040193254A1 (en) * | 2003-01-14 | 2004-09-30 | Greenberg Roy K. | Branched vessel endoluminal device |
US20050102021A1 (en) * | 2003-10-10 | 2005-05-12 | Cook Incorporated | Stretchable prosthesis fenestration |
US20050113905A1 (en) * | 2003-10-10 | 2005-05-26 | Greenberg Roy K. | Endoluminal prosthesis with interconnectable modules |
US20050149166A1 (en) * | 2003-11-08 | 2005-07-07 | Schaeffer Darin G. | Branch vessel prosthesis with anchoring device and method |
US20050222669A1 (en) * | 2004-03-31 | 2005-10-06 | Purdy James D | Fenestrated intraluminal stent system |
WO2006007389A1 (en) * | 2004-06-16 | 2006-01-19 | Cook Incorprated | Thoracic deployment device and stent graft |
US20060085061A1 (en) * | 1996-11-04 | 2006-04-20 | Vardi Gil M | Extendible stent apparatus and method for deploying the same |
US20060241740A1 (en) * | 1996-11-04 | 2006-10-26 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
WO2006127125A2 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Limited | Crimpable and expandable side branch cell |
US20060271160A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
US20060271161A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Selective treatment of stent side branch petals |
WO2006136145A1 (en) * | 2005-06-21 | 2006-12-28 | Charite-Universitätsmedizin Berlin | Stent for implanting in a human or animal vessel |
US20070032855A1 (en) * | 1998-01-14 | 2007-02-08 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US20070055351A1 (en) * | 2005-09-08 | 2007-03-08 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US20070055362A1 (en) * | 2005-09-08 | 2007-03-08 | Boston Scientific Scimed, Inc. | Overlapping stent |
US20070100437A1 (en) * | 2005-05-13 | 2007-05-03 | Alveolus, Inc. | Drainage stent and associated method |
US20070112418A1 (en) * | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
US20070118205A1 (en) * | 1999-01-13 | 2007-05-24 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20070123970A1 (en) * | 2005-11-29 | 2007-05-31 | Boston Scientific Scimed, Inc. | Bifurcation stent with overlapping crimped struts |
US20070135904A1 (en) * | 2005-12-14 | 2007-06-14 | Tracee Eidenschink | Telescoping bifurcated stent |
US20070135903A1 (en) * | 2005-12-14 | 2007-06-14 | Daniel Gregorich | Connectors for bifurcated stent |
US20070142902A1 (en) * | 2004-12-14 | 2007-06-21 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20070142904A1 (en) * | 2005-12-20 | 2007-06-21 | Boston Scientific Scimed, Inc. | Bifurcated stent with multiple locations for side branch access |
US20070168019A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
US20070168018A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US20070173920A1 (en) * | 1999-01-27 | 2007-07-26 | Boston Scientific Scimed, Inc. | Bifurcation stent delivery system |
US20070208256A1 (en) * | 2006-03-03 | 2007-09-06 | Medtronic Vascular, Inc. | Multiple Branch Tubular Prosthesis and Methods |
US20070208415A1 (en) * | 2006-03-06 | 2007-09-06 | Kevin Grotheim | Bifurcated stent with controlled drug delivery |
US20070208411A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent with surface area gradient |
US20070208419A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcation stent with uniform side branch projection |
US20070208418A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070213811A1 (en) * | 2006-03-07 | 2007-09-13 | Boston Scientific Scimed, Inc. | Bifurcated stent with improvement securement |
US20070225796A1 (en) * | 2004-03-17 | 2007-09-27 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070233233A1 (en) * | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc | Tethered expansion columns for controlled stent expansion |
US20070250154A1 (en) * | 2006-04-19 | 2007-10-25 | William A. Cook Australia Pty Ltd. | Twin bifurcated stent graft |
US20070293940A1 (en) * | 2006-06-06 | 2007-12-20 | Cook Incorporated | Stent with a crush-resistant zone |
EP1878392A1 (en) * | 2006-07-14 | 2008-01-16 | Cordis Corporation | AAA repair device with aneurysm sac access port |
US20080065188A1 (en) * | 2006-09-12 | 2008-03-13 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
WO2008057568A1 (en) * | 2006-11-07 | 2008-05-15 | William A. Cook Australia Pty. Ltd | Fenestrations for stent graft arrangements and stent graft including the same |
WO2008063328A1 (en) * | 2006-11-16 | 2008-05-29 | Boston Scientific Limited | Bifurcation stent design with over expansion capability |
US20080243221A1 (en) * | 2007-03-30 | 2008-10-02 | Boston Scientific Scimed, Inc. | Balloon fold design for deployment of bifurcated stent petal architecture |
US20080243232A1 (en) * | 2007-03-28 | 2008-10-02 | Boston Scientific Scimed, Inc. | Bifurcation stent and balloon assemblies |
WO2008086084A3 (en) * | 2007-01-05 | 2008-11-13 | Medtronic Vascular Inc | Branch vessel graft method and delivery system |
US20090012596A1 (en) * | 2007-07-06 | 2009-01-08 | Boston Scientific Scimed, Inc. | Stent with Bioabsorbable Membrane |
US20090012599A1 (en) * | 2007-07-06 | 2009-01-08 | Boston Scientific Scimed, Inc. | Biodegradable Connectors |
WO2009017632A2 (en) * | 2007-07-26 | 2009-02-05 | Med Institute, Inc. | Stent arrangement |
US20090043377A1 (en) * | 2003-01-14 | 2009-02-12 | The Cleveland Clinic Foundation | Branched Vessel Endoluminal Device |
US20090164001A1 (en) * | 2007-12-21 | 2009-06-25 | Biggs David P | Socket For Fenestrated Tubular Prosthesis |
US20090222078A1 (en) * | 2007-12-21 | 2009-09-03 | Greenberg Roy K | Prosthesis for Implantation in Aorta and Method of Using Same |
US20090259290A1 (en) * | 2008-04-14 | 2009-10-15 | Medtronic Vascular, Inc. | Fenestration Segment Stent-Graft and Fenestration Method |
US20090264985A1 (en) * | 2008-04-17 | 2009-10-22 | Medtronic Vascular, Inc. | Branch Vessel Suture Stent System and Method |
US20090287145A1 (en) * | 2008-05-15 | 2009-11-19 | Altura Interventional, Inc. | Devices and methods for treatment of abdominal aortic aneurysms |
WO2010024880A1 (en) * | 2008-08-29 | 2010-03-04 | Cook Incorporated | Implantable prosthesis with reduced density regions |
US7678142B2 (en) | 1996-11-04 | 2010-03-16 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US7731741B2 (en) | 2005-09-08 | 2010-06-08 | Boston Scientific Scimed, Inc. | Inflatable bifurcation stent |
US20100173066A1 (en) * | 2002-11-05 | 2010-07-08 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7758634B2 (en) | 2001-02-26 | 2010-07-20 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US20100241218A1 (en) * | 2009-03-23 | 2010-09-23 | Medtronic Vascular, Inc. | Branch Vessel Prosthesis With a Roll-Up Sealing Assembly |
US7815675B2 (en) | 1996-11-04 | 2010-10-19 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7833266B2 (en) | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US20100292772A1 (en) * | 2009-04-23 | 2010-11-18 | Samuels Shaun L W | Endovascular router device and method |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7922758B2 (en) | 2006-06-23 | 2011-04-12 | Boston Scientific Scimed, Inc. | Nesting twisting hinge points in a bifurcated petal geometry |
US7951191B2 (en) | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US7951192B2 (en) | 2001-09-24 | 2011-05-31 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7959668B2 (en) | 2007-01-16 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US8016878B2 (en) | 2005-12-22 | 2011-09-13 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US8206429B2 (en) | 2006-11-02 | 2012-06-26 | Boston Scientific Scimed, Inc. | Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
US8298280B2 (en) | 2003-08-21 | 2012-10-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20120323309A1 (en) * | 2009-12-23 | 2012-12-20 | Acandis Gmbh & Co. Kg | Stent with flaps |
WO2013074921A2 (en) * | 2011-11-17 | 2013-05-23 | Smouse Harry Robinson | Methods and apparatus for treating a type 2 endoleak from within an endoluminal stent graft |
US8480726B2 (en) | 2011-02-28 | 2013-07-09 | Cook Medical Technologies Llc | Stent graft with valve arrangement |
US8702786B2 (en) | 2010-08-21 | 2014-04-22 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8747456B2 (en) | 2007-12-31 | 2014-06-10 | Boston Scientific Scimed, Inc. | Bifurcation stent delivery system and methods |
US8771336B2 (en) | 2010-08-21 | 2014-07-08 | Cook Medical Technologies Llc | Endoluminal prosthesis comprising a valve replacement and at least one fenestration |
US8795349B2 (en) | 2010-08-21 | 2014-08-05 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8808355B2 (en) * | 2012-11-27 | 2014-08-19 | Cook Medical Technologies Llc | Stent graft having a closeable fenestration |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
US8870939B2 (en) | 2010-08-21 | 2014-10-28 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US9358141B2 (en) | 2004-03-31 | 2016-06-07 | Cook Medical Technologies Llc | Stent deployment device |
EP2506797A4 (en) * | 2009-11-30 | 2016-10-19 | Biflow Medical Ltd | Method of implanting a stent graft and creating a fenestration therein |
US9566149B2 (en) | 2010-11-16 | 2017-02-14 | W. L. Gore & Associates, Inc. | Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel |
US9572652B2 (en) | 2009-12-01 | 2017-02-21 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
US20170128246A1 (en) * | 2010-11-02 | 2017-05-11 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US9737426B2 (en) | 2013-03-15 | 2017-08-22 | Altura Medical, Inc. | Endograft device delivery systems and associated methods |
WO2017218474A1 (en) * | 2016-06-13 | 2017-12-21 | Aortica Corporation | Systems, devices, and methods for marking and/or reinforcing fenestrations in prosthetic implants |
WO2018077499A1 (en) | 2016-10-28 | 2018-05-03 | Hector Daniel Barone | Prosthesis for repairing a blood vessel and method |
US10265202B2 (en) | 2013-03-14 | 2019-04-23 | Cook Medical Technologies Llc | Prosthesis having an everting pivoting fenestration |
US10285833B2 (en) | 2012-08-10 | 2019-05-14 | Lombard Medical Limited | Stent delivery systems and associated methods |
US11000359B2 (en) | 2016-08-02 | 2021-05-11 | Aortica Corporation | Systems, devices, and methods for coupling a prosthetic implant to a fenestrated body |
US11052608B2 (en) | 2012-05-01 | 2021-07-06 | University Of Washington Through Its Center For Commercialization | Fenestration template for endovascular repair of aortic aneurysms |
US11278390B2 (en) | 2017-02-24 | 2022-03-22 | Bolton Medical, Inc. | Stent graft with fenestration lock and methods of use |
US11351025B2 (en) | 2017-02-24 | 2022-06-07 | Bolton Medical, Inc. | Vascular prosthesis with fenestration ring and methods of use |
US11369466B2 (en) | 2017-02-24 | 2022-06-28 | Bolton Medical, Inc. | Vascular prosthesis with moveable fenestration and method of use |
US11376145B2 (en) | 2017-10-31 | 2022-07-05 | Bolton Medical, Inc. | Distal torque component, delivery system and method of using same |
US11399929B2 (en) | 2017-02-24 | 2022-08-02 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
US11547584B2 (en) | 2017-02-24 | 2023-01-10 | Bolton Medical, Inc. | Delivery system and method to radially constrict a stent graft |
WO2023091098A1 (en) * | 2021-11-22 | 2023-05-25 | Mehmet Hakan Akpinar | An implantable patch for vascular injuries with a blood perfusion system |
US11730584B2 (en) | 2017-02-24 | 2023-08-22 | Bolton Medical, Inc. | System and method to radially constrict a stent graft |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062214B2 (en) | 2004-08-27 | 2011-11-22 | Smith & Nephew, Inc. | Tissue resecting system |
DE102006024245A1 (en) * | 2006-05-23 | 2007-08-02 | Siemens Ag | Medical instrument such as a neural implant, biopsy needle or an artificial landmark for implanting into human body, comprises a sample for permitting localization of the medical instruments into the human body, and transponder |
US9907680B2 (en) | 2015-04-10 | 2018-03-06 | Cook Medical Technologies Llc | Sliding fenestration |
CN111148484B (en) | 2017-09-25 | 2022-12-30 | 波尔顿医疗公司 | Systems, devices, and methods for coupling a prosthetic implant to an open window |
CN110236748B (en) * | 2019-05-30 | 2021-03-26 | 中国人民解放军陆军军医大学第一附属医院 | Exempt from to make accurate external windowing aortic support of order |
USD998779S1 (en) * | 2020-06-05 | 2023-09-12 | W. L. Gore & Associates, Inc. | Vent |
USD1004071S1 (en) * | 2020-11-30 | 2023-11-07 | W. L. Gore & Associates, Inc. | Vent |
Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4482516A (en) * | 1982-09-10 | 1984-11-13 | W. L. Gore & Associates, Inc. | Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure |
US4988356A (en) * | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
US5102403A (en) * | 1990-06-18 | 1992-04-07 | Eckhard Alt | Therapeutic medical instrument for insertion into body |
US5135535A (en) * | 1991-06-11 | 1992-08-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5171222A (en) * | 1988-03-10 | 1992-12-15 | Scimed Life Systems, Inc. | Interlocking peel-away dilation catheter |
US5195978A (en) * | 1991-12-11 | 1993-03-23 | Baxter International Inc. | Rapid exchange over-the-wire catheter with breakaway feature |
US5205822A (en) * | 1991-06-10 | 1993-04-27 | Cordis Corporation | Replaceable dilatation catheter |
US5324269A (en) * | 1991-09-19 | 1994-06-28 | Baxter International Inc. | Fully exchangeable dual lumen over-the-wire dilatation catheter with rip seam |
US5334147A (en) * | 1993-04-28 | 1994-08-02 | Cordis Corporation | Rapid exchange type dilatation catheter |
US5336184A (en) * | 1993-07-15 | 1994-08-09 | Teirstein Paul S | Rapid exchange catheter |
US5389087A (en) * | 1991-09-19 | 1995-02-14 | Baxter International Inc. | Fully exchangeable over-the-wire catheter with rip seam and gated side port |
US5395335A (en) * | 1991-05-24 | 1995-03-07 | Jang; G. David | Universal mode vascular catheter system |
US5472425A (en) * | 1993-07-15 | 1995-12-05 | Teirstein; Paul S. | Rapid exchange catheter |
US5476589A (en) * | 1995-03-10 | 1995-12-19 | W. L. Gore & Associates, Inc. | Porpous PTFE film and a manufacturing method therefor |
US5489271A (en) * | 1994-03-29 | 1996-02-06 | Boston Scientific Corporation | Convertible catheter |
US5683448A (en) * | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
US5807355A (en) * | 1996-12-09 | 1998-09-15 | Advanced Cardiovascular Systems, Inc. | Catheter with rapid exchange and OTW operative modes |
US5824043A (en) * | 1994-03-09 | 1998-10-20 | Cordis Corporation | Endoprosthesis having graft member and exposed welded end junctions, method and procedure |
US5993489A (en) * | 1993-08-18 | 1999-11-30 | W. L. Gore & Associates, Inc. | Tubular intraluminal graft and stent combination |
US6071307A (en) * | 1998-09-30 | 2000-06-06 | Baxter International Inc. | Endoluminal grafts having continuously curvilinear wireforms |
US6095990A (en) * | 1998-08-31 | 2000-08-01 | Parodi; Juan Carlos | Guiding device and method for inserting and advancing catheters and guidewires into a vessel of a patient in endovascular treatments |
US6245100B1 (en) * | 2000-02-01 | 2001-06-12 | Cordis Corporation | Method for making a self-expanding stent-graft |
US6299595B1 (en) * | 1999-12-17 | 2001-10-09 | Advanced Cardiovascular Systems, Inc. | Catheters having rapid-exchange and over-the-wire operating modes |
US6327772B1 (en) * | 1996-01-30 | 2001-12-11 | Medtronic, Inc. | Method for fabricating a planar eversible lattice which forms a stent when everted |
US6355056B1 (en) * | 1995-06-01 | 2002-03-12 | Meadox Medicals, Inc. | Implantable intraluminal prosthesis |
US6395018B1 (en) * | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US6428565B1 (en) * | 1997-09-11 | 2002-08-06 | Medtronic Ave, Inc. | System and method for edoluminal grafting of bifurcated or branched vessels |
US6432127B1 (en) * | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US6511505B2 (en) * | 1999-04-22 | 2003-01-28 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6579314B1 (en) * | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US20030130720A1 (en) * | 2002-01-08 | 2003-07-10 | Depalma Donald F. | Modular aneurysm repair system |
US6599315B2 (en) * | 1999-12-15 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US20040054403A1 (en) * | 2002-09-18 | 2004-03-18 | Israel Henry M | Angular orientation of a stent |
US6835203B1 (en) * | 1996-11-04 | 2004-12-28 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6896694B1 (en) * | 1999-05-17 | 2005-05-24 | Fundaco Zerbini A Brazilian Foundation | Device for disobstruction of ateriosclerotic lesions which incorporate the origin of lateral branches, or which are located in bifurcation of the coronary circulation, and respective interventionist process of placing such device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990010304A (en) * | 1997-07-16 | 1999-02-18 | 장양수 | Blood vessel stent |
WO1999026559A1 (en) * | 1997-11-25 | 1999-06-03 | Triad Vascular Systems, Inc. | Layered endovascular graft |
AUPP083597A0 (en) * | 1997-12-10 | 1998-01-08 | William A Cook Australia Pty Ltd | Endoluminal aortic stents |
US6261273B1 (en) * | 1998-05-07 | 2001-07-17 | Carlos E. Ruiz | Access system for branched vessels amd methods of use |
US6673103B1 (en) * | 1999-05-20 | 2004-01-06 | Scimed Life Systems, Inc. | Mesh and stent for increased flexibility |
JP2004529735A (en) * | 2001-06-18 | 2004-09-30 | イーバ コーポレイション | Prosthetic implants and their use |
-
2002
- 2002-09-20 US US10/251,031 patent/US20040059406A1/en not_active Abandoned
-
2003
- 2003-09-16 DE DE60302674T patent/DE60302674T2/en not_active Expired - Lifetime
- 2003-09-16 AT AT03754655T patent/ATE311834T1/en not_active IP Right Cessation
- 2003-09-16 AU AU2003272473A patent/AU2003272473B2/en not_active Expired
- 2003-09-16 WO PCT/US2003/029200 patent/WO2004026181A1/en active IP Right Grant
- 2003-09-16 EP EP03754655A patent/EP1539037B1/en not_active Expired - Lifetime
- 2003-09-16 CA CA002498176A patent/CA2498176C/en not_active Expired - Lifetime
- 2003-09-16 JP JP2004537900A patent/JP4571498B2/en not_active Expired - Lifetime
-
2013
- 2013-07-31 US US13/955,899 patent/US9694108B2/en not_active Expired - Lifetime
Patent Citations (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4482516A (en) * | 1982-09-10 | 1984-11-13 | W. L. Gore & Associates, Inc. | Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure |
US4988356A (en) * | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
US5171222A (en) * | 1988-03-10 | 1992-12-15 | Scimed Life Systems, Inc. | Interlocking peel-away dilation catheter |
US5102403A (en) * | 1990-06-18 | 1992-04-07 | Eckhard Alt | Therapeutic medical instrument for insertion into body |
US5395335A (en) * | 1991-05-24 | 1995-03-07 | Jang; G. David | Universal mode vascular catheter system |
US5205822A (en) * | 1991-06-10 | 1993-04-27 | Cordis Corporation | Replaceable dilatation catheter |
US5135535A (en) * | 1991-06-11 | 1992-08-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US6398799B2 (en) * | 1991-06-11 | 2002-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5324269A (en) * | 1991-09-19 | 1994-06-28 | Baxter International Inc. | Fully exchangeable dual lumen over-the-wire dilatation catheter with rip seam |
US5389087A (en) * | 1991-09-19 | 1995-02-14 | Baxter International Inc. | Fully exchangeable over-the-wire catheter with rip seam and gated side port |
US5195978A (en) * | 1991-12-11 | 1993-03-23 | Baxter International Inc. | Rapid exchange over-the-wire catheter with breakaway feature |
US5683448A (en) * | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
US5334147A (en) * | 1993-04-28 | 1994-08-02 | Cordis Corporation | Rapid exchange type dilatation catheter |
US5380283A (en) * | 1993-04-28 | 1995-01-10 | Cordis Corporation | Rapid exchange type dilatation catheter |
US5336184A (en) * | 1993-07-15 | 1994-08-09 | Teirstein Paul S | Rapid exchange catheter |
US5472425A (en) * | 1993-07-15 | 1995-12-05 | Teirstein; Paul S. | Rapid exchange catheter |
US5993489A (en) * | 1993-08-18 | 1999-11-30 | W. L. Gore & Associates, Inc. | Tubular intraluminal graft and stent combination |
US5824043A (en) * | 1994-03-09 | 1998-10-20 | Cordis Corporation | Endoprosthesis having graft member and exposed welded end junctions, method and procedure |
US5919164A (en) * | 1994-03-29 | 1999-07-06 | Boston Scientific Corporation | Convertible catheter and the like |
US5489271A (en) * | 1994-03-29 | 1996-02-06 | Boston Scientific Corporation | Convertible catheter |
US5476589A (en) * | 1995-03-10 | 1995-12-19 | W. L. Gore & Associates, Inc. | Porpous PTFE film and a manufacturing method therefor |
US6579314B1 (en) * | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6355056B1 (en) * | 1995-06-01 | 2002-03-12 | Meadox Medicals, Inc. | Implantable intraluminal prosthesis |
US6327772B1 (en) * | 1996-01-30 | 2001-12-11 | Medtronic, Inc. | Method for fabricating a planar eversible lattice which forms a stent when everted |
US6432127B1 (en) * | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US6835203B1 (en) * | 1996-11-04 | 2004-12-28 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US5807355A (en) * | 1996-12-09 | 1998-09-15 | Advanced Cardiovascular Systems, Inc. | Catheter with rapid exchange and OTW operative modes |
US6428565B1 (en) * | 1997-09-11 | 2002-08-06 | Medtronic Ave, Inc. | System and method for edoluminal grafting of bifurcated or branched vessels |
US6395018B1 (en) * | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US6095990A (en) * | 1998-08-31 | 2000-08-01 | Parodi; Juan Carlos | Guiding device and method for inserting and advancing catheters and guidewires into a vessel of a patient in endovascular treatments |
US6071307A (en) * | 1998-09-30 | 2000-06-06 | Baxter International Inc. | Endoluminal grafts having continuously curvilinear wireforms |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US6511505B2 (en) * | 1999-04-22 | 2003-01-28 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6896694B1 (en) * | 1999-05-17 | 2005-05-24 | Fundaco Zerbini A Brazilian Foundation | Device for disobstruction of ateriosclerotic lesions which incorporate the origin of lateral branches, or which are located in bifurcation of the coronary circulation, and respective interventionist process of placing such device |
US6599315B2 (en) * | 1999-12-15 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US6299595B1 (en) * | 1999-12-17 | 2001-10-09 | Advanced Cardiovascular Systems, Inc. | Catheters having rapid-exchange and over-the-wire operating modes |
US6245100B1 (en) * | 2000-02-01 | 2001-06-12 | Cordis Corporation | Method for making a self-expanding stent-graft |
US20030130720A1 (en) * | 2002-01-08 | 2003-07-10 | Depalma Donald F. | Modular aneurysm repair system |
US20040054403A1 (en) * | 2002-09-18 | 2004-03-18 | Israel Henry M | Angular orientation of a stent |
Cited By (196)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060085061A1 (en) * | 1996-11-04 | 2006-04-20 | Vardi Gil M | Extendible stent apparatus and method for deploying the same |
US7678142B2 (en) | 1996-11-04 | 2010-03-16 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US7766955B2 (en) | 1996-11-04 | 2010-08-03 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US7815675B2 (en) | 1996-11-04 | 2010-10-19 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7850725B2 (en) * | 1996-11-04 | 2010-12-14 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US20060241740A1 (en) * | 1996-11-04 | 2006-10-26 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7892279B2 (en) | 1998-01-14 | 2011-02-22 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US20070032855A1 (en) * | 1998-01-14 | 2007-02-08 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US8241349B2 (en) | 1998-01-14 | 2012-08-14 | Boston Scientific Scimed, Inc. | Extendible stent apparatus |
US8257425B2 (en) | 1999-01-13 | 2012-09-04 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20070118205A1 (en) * | 1999-01-13 | 2007-05-24 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20070173920A1 (en) * | 1999-01-27 | 2007-07-26 | Boston Scientific Scimed, Inc. | Bifurcation stent delivery system |
US20030195606A1 (en) * | 1999-09-23 | 2003-10-16 | Advanced Stent Technologies, Inc., A Delaware Corporation | Bifurcation stent system and method |
US7758634B2 (en) | 2001-02-26 | 2010-07-20 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US8425590B2 (en) | 2001-09-24 | 2013-04-23 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7951192B2 (en) | 2001-09-24 | 2011-05-31 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20040117860A1 (en) * | 2002-09-19 | 2004-06-17 | Lg Electronics Inc. | Multicast service providing method in mobile communication system |
US20040127973A1 (en) * | 2002-11-05 | 2004-07-01 | Mangiardi Eric K. | Removable biliary stent |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US20100173066A1 (en) * | 2002-11-05 | 2010-07-08 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US20040127974A1 (en) * | 2002-11-05 | 2004-07-01 | Mangiardi Eric K. | Differential covering and coating methods |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US8206436B2 (en) | 2002-11-05 | 2012-06-26 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US9125733B2 (en) | 2003-01-14 | 2015-09-08 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US7105020B2 (en) | 2003-01-14 | 2006-09-12 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US9943400B2 (en) | 2003-01-14 | 2018-04-17 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US20040193254A1 (en) * | 2003-01-14 | 2004-09-30 | Greenberg Roy K. | Branched vessel endoluminal device |
US10631972B2 (en) | 2003-01-14 | 2020-04-28 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US20090043377A1 (en) * | 2003-01-14 | 2009-02-12 | The Cleveland Clinic Foundation | Branched Vessel Endoluminal Device |
US8298280B2 (en) | 2003-08-21 | 2012-10-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US8808351B2 (en) * | 2003-10-10 | 2014-08-19 | Cook Medical Technologies Llc | Stretchable prosthesis fenestration |
US20050102021A1 (en) * | 2003-10-10 | 2005-05-12 | Cook Incorporated | Stretchable prosthesis fenestration |
US20050113905A1 (en) * | 2003-10-10 | 2005-05-26 | Greenberg Roy K. | Endoluminal prosthesis with interconnectable modules |
US20070179592A1 (en) * | 2003-11-08 | 2007-08-02 | Schaeffer Darin G | Branch vessel prosthesis with positional indicator system and method |
US8287586B2 (en) | 2003-11-08 | 2012-10-16 | Cook Medical Technologies Llc | Flareable branch vessel prosthesis and method |
US20050149166A1 (en) * | 2003-11-08 | 2005-07-07 | Schaeffer Darin G. | Branch vessel prosthesis with anchoring device and method |
US9974674B2 (en) | 2003-11-08 | 2018-05-22 | Cook Medical Technologies Llc | Branch vessel prothesis with positional indicator system and method |
US9078780B2 (en) * | 2003-11-08 | 2015-07-14 | Cook Medical Technologies Llc | Balloon flareable branch vessel prosthesis and method |
US20050171597A1 (en) * | 2003-11-08 | 2005-08-04 | Boatman Scott E. | Helical stent for branched vessel prosthesis |
US9095461B2 (en) | 2003-11-08 | 2015-08-04 | Cook Medical Technologies Llc | Aorta and branch vessel stent grafts and method |
US20050171598A1 (en) * | 2003-11-08 | 2005-08-04 | Schaeffer Darin G. | Aorta and branch vessel stent grafts and method |
US20060058864A1 (en) * | 2003-11-08 | 2006-03-16 | Schaeffer Darin G | Balloon flareable branch vessel prosthesis and method |
US20050222668A1 (en) * | 2003-11-08 | 2005-10-06 | Schaeffer Darin G | Flareable branch vessel prosthesis and method |
US8007528B2 (en) | 2004-03-17 | 2011-08-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070225796A1 (en) * | 2004-03-17 | 2007-09-27 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US9358141B2 (en) | 2004-03-31 | 2016-06-07 | Cook Medical Technologies Llc | Stent deployment device |
US20050222669A1 (en) * | 2004-03-31 | 2005-10-06 | Purdy James D | Fenestrated intraluminal stent system |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US8523934B2 (en) | 2004-03-31 | 2013-09-03 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
WO2006007389A1 (en) * | 2004-06-16 | 2006-01-19 | Cook Incorprated | Thoracic deployment device and stent graft |
US8758425B2 (en) | 2004-06-16 | 2014-06-24 | The Cleveland Clinic Foundation | Thoracic deployment device and stent graft |
US20070142902A1 (en) * | 2004-12-14 | 2007-06-21 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US9427340B2 (en) | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20070100437A1 (en) * | 2005-05-13 | 2007-05-03 | Alveolus, Inc. | Drainage stent and associated method |
US8262721B2 (en) * | 2005-05-13 | 2012-09-11 | Merit Medical Systems, Inc. | Drainage stent and associated method |
US8480728B2 (en) | 2005-05-26 | 2013-07-09 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
WO2006127125A3 (en) * | 2005-05-26 | 2007-04-19 | Boston Scient Scimed Inc | Crimpable and expandable side branch cell |
US8317855B2 (en) | 2005-05-26 | 2012-11-27 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
US20060271161A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Selective treatment of stent side branch petals |
US20060271159A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
US20060271160A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
WO2006127125A2 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Limited | Crimpable and expandable side branch cell |
WO2006136145A1 (en) * | 2005-06-21 | 2006-12-28 | Charite-Universitätsmedizin Berlin | Stent for implanting in a human or animal vessel |
US20070055351A1 (en) * | 2005-09-08 | 2007-03-08 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US7731741B2 (en) | 2005-09-08 | 2010-06-08 | Boston Scientific Scimed, Inc. | Inflatable bifurcation stent |
US20070055362A1 (en) * | 2005-09-08 | 2007-03-08 | Boston Scientific Scimed, Inc. | Overlapping stent |
US8043366B2 (en) | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
US8038706B2 (en) | 2005-09-08 | 2011-10-18 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US7842081B2 (en) | 2005-11-14 | 2010-11-30 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch |
US20070112418A1 (en) * | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
US20070123970A1 (en) * | 2005-11-29 | 2007-05-31 | Boston Scientific Scimed, Inc. | Bifurcation stent with overlapping crimped struts |
WO2007064371A1 (en) * | 2005-11-29 | 2007-06-07 | Boston Scientific Limited | Bifurcation stent with overlapping crimped struts |
US8343211B2 (en) | 2005-12-14 | 2013-01-01 | Boston Scientific Scimed, Inc. | Connectors for bifurcated stent |
US20070135904A1 (en) * | 2005-12-14 | 2007-06-14 | Tracee Eidenschink | Telescoping bifurcated stent |
US20070135903A1 (en) * | 2005-12-14 | 2007-06-14 | Daniel Gregorich | Connectors for bifurcated stent |
US8435284B2 (en) | 2005-12-14 | 2013-05-07 | Boston Scientific Scimed, Inc. | Telescoping bifurcated stent |
WO2007073410A1 (en) * | 2005-12-20 | 2007-06-28 | Boston Scientific Limited | Bifurcated stent with multiple side branch access |
US20070142904A1 (en) * | 2005-12-20 | 2007-06-21 | Boston Scientific Scimed, Inc. | Bifurcated stent with multiple locations for side branch access |
US8016878B2 (en) | 2005-12-22 | 2011-09-13 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US8900287B2 (en) | 2006-01-13 | 2014-12-02 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US8778008B2 (en) | 2006-01-13 | 2014-07-15 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
US20070168018A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US20070168019A1 (en) * | 2006-01-13 | 2007-07-19 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
US20070208256A1 (en) * | 2006-03-03 | 2007-09-06 | Medtronic Vascular, Inc. | Multiple Branch Tubular Prosthesis and Methods |
US20070208415A1 (en) * | 2006-03-06 | 2007-09-06 | Kevin Grotheim | Bifurcated stent with controlled drug delivery |
US7833264B2 (en) | 2006-03-06 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070208411A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent with surface area gradient |
US20070208419A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcation stent with uniform side branch projection |
US20070208418A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070213811A1 (en) * | 2006-03-07 | 2007-09-13 | Boston Scientific Scimed, Inc. | Bifurcated stent with improvement securement |
US8298278B2 (en) | 2006-03-07 | 2012-10-30 | Boston Scientific Scimed, Inc. | Bifurcated stent with improvement securement |
US20070233233A1 (en) * | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc | Tethered expansion columns for controlled stent expansion |
US20070250154A1 (en) * | 2006-04-19 | 2007-10-25 | William A. Cook Australia Pty Ltd. | Twin bifurcated stent graft |
US10143576B2 (en) | 2006-04-19 | 2018-12-04 | Cook Medical Technologies Llc | Twin bifurcated stent graft |
US9707113B2 (en) | 2006-04-19 | 2017-07-18 | Cook Medical Technologies Llc | Twin bifurcated stent graft |
US20070293940A1 (en) * | 2006-06-06 | 2007-12-20 | Cook Incorporated | Stent with a crush-resistant zone |
US11241320B2 (en) | 2006-06-06 | 2022-02-08 | Cook Medical Technologies Llc | Stent with a crush-resistant zone |
US10357386B2 (en) | 2006-06-06 | 2019-07-23 | Cook Medical Technologies Llc | Stent with a crush-resistant zone |
US9259336B2 (en) | 2006-06-06 | 2016-02-16 | Cook Medical Technologies Llc | Stent with a crush-resistant zone |
US10675163B2 (en) | 2006-06-06 | 2020-06-09 | Cook Medical Technologies Llc | Stent with a crush-resistant zone |
US7922758B2 (en) | 2006-06-23 | 2011-04-12 | Boston Scientific Scimed, Inc. | Nesting twisting hinge points in a bifurcated petal geometry |
US8202310B2 (en) | 2006-07-14 | 2012-06-19 | Cordis Corporation | AAA repair device with aneurysm sac access port |
EP1878392A1 (en) * | 2006-07-14 | 2008-01-16 | Cordis Corporation | AAA repair device with aneurysm sac access port |
US9492297B2 (en) | 2006-09-12 | 2016-11-15 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US20080065188A1 (en) * | 2006-09-12 | 2008-03-13 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US8216267B2 (en) | 2006-09-12 | 2012-07-10 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US7951191B2 (en) | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US8556955B2 (en) | 2006-11-02 | 2013-10-15 | Boston Scientific Scimed, Inc. | Adjustable bifurcation catheter incorporating electroactive polymer and methods of makings and using the same |
US8206429B2 (en) | 2006-11-02 | 2012-06-26 | Boston Scientific Scimed, Inc. | Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same |
US20080114446A1 (en) * | 2006-11-07 | 2008-05-15 | Wiiliam A. Cook Australia Pty Ltd. | Fenestration for stent graft arrangements and stent graft including the same |
WO2008057568A1 (en) * | 2006-11-07 | 2008-05-15 | William A. Cook Australia Pty. Ltd | Fenestrations for stent graft arrangements and stent graft including the same |
US8167926B2 (en) | 2006-11-07 | 2012-05-01 | Cook Medical Technologies Llc | Fenestration for stent graft arrangements and stent graft including the same |
AU2007317777B2 (en) * | 2006-11-07 | 2012-08-02 | Cook Incorporated | Fenestrations for stent graft arrangements and stent graft including the same |
US20080177377A1 (en) * | 2006-11-16 | 2008-07-24 | Boston Scientific Scimed, Inc. | Bifurcation Stent Design with Over Expansion Capability |
WO2008063328A1 (en) * | 2006-11-16 | 2008-05-29 | Boston Scientific Limited | Bifurcation stent design with over expansion capability |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
WO2008086084A3 (en) * | 2007-01-05 | 2008-11-13 | Medtronic Vascular Inc | Branch vessel graft method and delivery system |
US8216298B2 (en) | 2007-01-05 | 2012-07-10 | Medtronic Vascular, Inc. | Branch vessel graft method and delivery system |
US7959668B2 (en) | 2007-01-16 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US8118861B2 (en) | 2007-03-28 | 2012-02-21 | Boston Scientific Scimed, Inc. | Bifurcation stent and balloon assemblies |
US20080243232A1 (en) * | 2007-03-28 | 2008-10-02 | Boston Scientific Scimed, Inc. | Bifurcation stent and balloon assemblies |
US20080243221A1 (en) * | 2007-03-30 | 2008-10-02 | Boston Scientific Scimed, Inc. | Balloon fold design for deployment of bifurcated stent petal architecture |
US8647376B2 (en) | 2007-03-30 | 2014-02-11 | Boston Scientific Scimed, Inc. | Balloon fold design for deployment of bifurcated stent petal architecture |
US7632305B2 (en) | 2007-07-06 | 2009-12-15 | Boston Scientific Scimed, Inc. | Biodegradable connectors |
WO2009009311A2 (en) * | 2007-07-06 | 2009-01-15 | Boston Scientific Limited | Bifurcated stent with bioabsorbable members |
US20090012596A1 (en) * | 2007-07-06 | 2009-01-08 | Boston Scientific Scimed, Inc. | Stent with Bioabsorbable Membrane |
CN101917940A (en) * | 2007-07-06 | 2010-12-15 | 波士顿科学有限公司 | The support that has bioabsorbable membrane |
US20090012599A1 (en) * | 2007-07-06 | 2009-01-08 | Boston Scientific Scimed, Inc. | Biodegradable Connectors |
WO2009009311A3 (en) * | 2007-07-06 | 2009-03-05 | Boston Scient Scimed Inc | Bifurcated stent with bioabsorbable members |
WO2009009376A3 (en) * | 2007-07-06 | 2009-03-05 | Boston Scient Scimed Inc | Stent with bioabsorbable membrane |
US7637940B2 (en) | 2007-07-06 | 2009-12-29 | Boston Scientific Scimed, Inc. | Stent with bioabsorbable membrane |
US20100070023A1 (en) * | 2007-07-06 | 2010-03-18 | Boston Scientific Scimed, Inc. | Biodegradable connectors |
WO2009017632A2 (en) * | 2007-07-26 | 2009-02-05 | Med Institute, Inc. | Stent arrangement |
WO2009017632A3 (en) * | 2007-07-26 | 2009-03-19 | Med Inst Inc | Stent arrangement |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US7833266B2 (en) | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US20090164001A1 (en) * | 2007-12-21 | 2009-06-25 | Biggs David P | Socket For Fenestrated Tubular Prosthesis |
US8002816B2 (en) | 2007-12-21 | 2011-08-23 | Cleveland Clinic Foundation | Prosthesis for implantation in aorta and method of using same |
US20090222078A1 (en) * | 2007-12-21 | 2009-09-03 | Greenberg Roy K | Prosthesis for Implantation in Aorta and Method of Using Same |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
US8747456B2 (en) | 2007-12-31 | 2014-06-10 | Boston Scientific Scimed, Inc. | Bifurcation stent delivery system and methods |
US20090259290A1 (en) * | 2008-04-14 | 2009-10-15 | Medtronic Vascular, Inc. | Fenestration Segment Stent-Graft and Fenestration Method |
US20090264985A1 (en) * | 2008-04-17 | 2009-10-22 | Medtronic Vascular, Inc. | Branch Vessel Suture Stent System and Method |
US20090287145A1 (en) * | 2008-05-15 | 2009-11-19 | Altura Interventional, Inc. | Devices and methods for treatment of abdominal aortic aneurysms |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
WO2010024880A1 (en) * | 2008-08-29 | 2010-03-04 | Cook Incorporated | Implantable prosthesis with reduced density regions |
US8353943B2 (en) | 2008-08-29 | 2013-01-15 | Cook Medical Technologies Llc | Variable weave graft with metal strand reinforcement for in situ fenestration |
US20100161025A1 (en) * | 2008-08-29 | 2010-06-24 | Cook, Incorporated | Variable weave graft with metal strand reinforcement for in situ fenestration |
US8052741B2 (en) | 2009-03-23 | 2011-11-08 | Medtronic Vascular, Inc. | Branch vessel prosthesis with a roll-up sealing assembly |
US20100241218A1 (en) * | 2009-03-23 | 2010-09-23 | Medtronic Vascular, Inc. | Branch Vessel Prosthesis With a Roll-Up Sealing Assembly |
US20100292772A1 (en) * | 2009-04-23 | 2010-11-18 | Samuels Shaun L W | Endovascular router device and method |
US10137018B2 (en) * | 2009-04-23 | 2018-11-27 | Shaun L. W. Samuels | Endovascular router device and method |
EP2506797A4 (en) * | 2009-11-30 | 2016-10-19 | Biflow Medical Ltd | Method of implanting a stent graft and creating a fenestration therein |
US9572652B2 (en) | 2009-12-01 | 2017-02-21 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
US20120323309A1 (en) * | 2009-12-23 | 2012-12-20 | Acandis Gmbh & Co. Kg | Stent with flaps |
US8852267B2 (en) * | 2009-12-23 | 2014-10-07 | Acandis GmbH & Co. | Stent with flaps |
US10159560B2 (en) | 2010-08-21 | 2018-12-25 | Cook Medical Technologies, LLC | Prosthesis having pivoting fenestration |
US8795349B2 (en) | 2010-08-21 | 2014-08-05 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8870939B2 (en) | 2010-08-21 | 2014-10-28 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8771336B2 (en) | 2010-08-21 | 2014-07-08 | Cook Medical Technologies Llc | Endoluminal prosthesis comprising a valve replacement and at least one fenestration |
US10188503B2 (en) | 2010-08-21 | 2019-01-29 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US9801706B2 (en) | 2010-08-21 | 2017-10-31 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US9808334B2 (en) | 2010-08-21 | 2017-11-07 | Cook Medical Technologies, LLC | Prothesis having pivoting fenestration |
US8702786B2 (en) | 2010-08-21 | 2014-04-22 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US9468544B2 (en) | 2010-08-21 | 2016-10-18 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US9277984B2 (en) | 2010-08-21 | 2016-03-08 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
US20170128246A1 (en) * | 2010-11-02 | 2017-05-11 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US11406518B2 (en) * | 2010-11-02 | 2022-08-09 | Endologix Llc | Apparatus and method of placement of a graft or graft system |
US9566149B2 (en) | 2010-11-16 | 2017-02-14 | W. L. Gore & Associates, Inc. | Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel |
US8480726B2 (en) | 2011-02-28 | 2013-07-09 | Cook Medical Technologies Llc | Stent graft with valve arrangement |
WO2013074921A2 (en) * | 2011-11-17 | 2013-05-23 | Smouse Harry Robinson | Methods and apparatus for treating a type 2 endoleak from within an endoluminal stent graft |
US9168162B2 (en) | 2011-11-17 | 2015-10-27 | Elgco, Llc | Methods and apparatus for treating a type 2 endoleak from within an endoluminal stent |
WO2013074921A3 (en) * | 2011-11-17 | 2013-07-04 | Smouse Harry Robinson | Methods and apparatus for treating a type 2 endoleak from within an endoluminal stent graft |
US11052608B2 (en) | 2012-05-01 | 2021-07-06 | University Of Washington Through Its Center For Commercialization | Fenestration template for endovascular repair of aortic aneurysms |
US10285833B2 (en) | 2012-08-10 | 2019-05-14 | Lombard Medical Limited | Stent delivery systems and associated methods |
US8808355B2 (en) * | 2012-11-27 | 2014-08-19 | Cook Medical Technologies Llc | Stent graft having a closeable fenestration |
US10265202B2 (en) | 2013-03-14 | 2019-04-23 | Cook Medical Technologies Llc | Prosthesis having an everting pivoting fenestration |
US9737426B2 (en) | 2013-03-15 | 2017-08-22 | Altura Medical, Inc. | Endograft device delivery systems and associated methods |
US10987235B2 (en) * | 2016-06-13 | 2021-04-27 | Aortica Corporation | Systems, devices, and methods for marking and/or reinforcing fenestrations in prosthetic implants |
CN109803607A (en) * | 2016-06-13 | 2019-05-24 | 主动脉公司 | For marking and/or reinforcing the systems, devices and methods to open a window in prothesis implant body |
US20210212845A1 (en) * | 2016-06-13 | 2021-07-15 | Aortica Corporation | Systems, devices, and methods for marking and/or reinforcing fenestrations in prosthetic implants |
WO2017218474A1 (en) * | 2016-06-13 | 2017-12-21 | Aortica Corporation | Systems, devices, and methods for marking and/or reinforcing fenestrations in prosthetic implants |
US11000359B2 (en) | 2016-08-02 | 2021-05-11 | Aortica Corporation | Systems, devices, and methods for coupling a prosthetic implant to a fenestrated body |
WO2018077499A1 (en) | 2016-10-28 | 2018-05-03 | Hector Daniel Barone | Prosthesis for repairing a blood vessel and method |
US10912638B2 (en) * | 2016-10-28 | 2021-02-09 | Hector Daniel Barone | Prosthesis for repairing a blood vessel and method |
US11351025B2 (en) | 2017-02-24 | 2022-06-07 | Bolton Medical, Inc. | Vascular prosthesis with fenestration ring and methods of use |
US11369466B2 (en) | 2017-02-24 | 2022-06-28 | Bolton Medical, Inc. | Vascular prosthesis with moveable fenestration and method of use |
US11779454B2 (en) | 2017-02-24 | 2023-10-10 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
US11399929B2 (en) | 2017-02-24 | 2022-08-02 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
US11278390B2 (en) | 2017-02-24 | 2022-03-22 | Bolton Medical, Inc. | Stent graft with fenestration lock and methods of use |
US11547584B2 (en) | 2017-02-24 | 2023-01-10 | Bolton Medical, Inc. | Delivery system and method to radially constrict a stent graft |
US11801129B2 (en) | 2017-02-24 | 2023-10-31 | Bolton Medical, Inc. | Vascular prosthesis with fenestration ring and methods of use |
US11730584B2 (en) | 2017-02-24 | 2023-08-22 | Bolton Medical, Inc. | System and method to radially constrict a stent graft |
US11376145B2 (en) | 2017-10-31 | 2022-07-05 | Bolton Medical, Inc. | Distal torque component, delivery system and method of using same |
WO2023091098A1 (en) * | 2021-11-22 | 2023-05-25 | Mehmet Hakan Akpinar | An implantable patch for vascular injuries with a blood perfusion system |
Also Published As
Publication number | Publication date |
---|---|
DE60302674T2 (en) | 2006-08-31 |
JP2006500107A (en) | 2006-01-05 |
CA2498176A1 (en) | 2004-04-01 |
DE60302674D1 (en) | 2006-01-12 |
ATE311834T1 (en) | 2005-12-15 |
WO2004026181A1 (en) | 2004-04-01 |
US20130317601A1 (en) | 2013-11-28 |
US9694108B2 (en) | 2017-07-04 |
EP1539037B1 (en) | 2005-12-07 |
JP4571498B2 (en) | 2010-10-27 |
CA2498176C (en) | 2009-05-12 |
AU2003272473B2 (en) | 2006-12-07 |
EP1539037A1 (en) | 2005-06-15 |
AU2003272473A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9694108B2 (en) | Medical device ameneable to fenestration | |
US10682222B2 (en) | Modular vascular graft for low profile percutaneous delivery | |
US20200330214A1 (en) | Apparatus and methods for endoluminal graft placement | |
US11065097B2 (en) | Advanced kink-resistant stent graft | |
EP1734899B1 (en) | Encapsulated stent-graft with graft to graft attachment | |
US6673103B1 (en) | Mesh and stent for increased flexibility | |
US6881221B2 (en) | Tubular structure/stent/stent securement member | |
US20140005764A1 (en) | Sealing mechanism for expandable vascular device | |
KR20160140688A (en) | Stent assembly for thoracoabdominal bifurcated aneurysm repair | |
KR20010041603A (en) | Endoluminal Vascular Prosthesis | |
JP5318604B2 (en) | Method and apparatus for attaching a stent structure to an AAA graft material | |
KR20020012574A (en) | Stent-graft with increased flexibility | |
JP2020533080A (en) | Intraluminal artificial vascular system | |
US20220257363A1 (en) | Bifurcated stent grafts, stents, and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GORE ENTERPRISE HOLDINGS, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CULLY, EDWARD H.;CUTRIGHT, WARREN J.;NORDHAUSEN, CRAIG T.;AND OTHERS;REEL/FRAME:013327/0970 Effective date: 20020919 |
|
AS | Assignment |
Owner name: W. L. GORE & ASSOCIATES, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GORE ENTERPRISE HOLDINGS, INC.;REEL/FRAME:027906/0508 Effective date: 20120130 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |